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1. TRPV1 channels 
The transient receptor  potential vanilloid type 1(TRPV1) , also known as vanilloid 
receptor , is a non-selective cationic channel. It belongs to the transient receptor 
potential channels (TRP) superfamily, which have been described for the first time 
in Drosophila phototrasduction1. Differently from other ion channels, TRP are 
grouped for their homology rather than their functions, as documented by their 
different roles in yeast ,protists and mammals. Mammalian TRP channels consist 
of six related protein subfamilies, with an homology lower than 20%: TRPC( 
classical),TRPV(vanilloid),TRPM(melastatin),TRPP(polycystin),TRPML(mucolipin),TR
PA(ankyrin) fig1.  All these channels comprise six trans-membrane domains that 
assemble as tetramers to form a cation-permeable pores 2. 
TRPV1 was cloned first ,thus representing the lead of TRPV subfamily. TRPV1s are 
calcium-permeable, non selective cation channels.  Current-voltage relationship 
experiments demonstrated that TRPV1 does not discriminate between 
monovalent cations and shows a particular preference for divalent 
cations(Ca2+>Mg2+>Na+=K+=Cs+). Regarding calcium permeability these channels 
exhibit a very high related PCA/PNA ratio similar to the value reported for the 
glutamate receptor N-Methyl-D-aspartate (NMDA): TRPV1 PCA/PNA=9.60, NMDA 
PCA/PNA=10.6 
3,4.  
Structurally, TRPV1 has six trans-membrane domains  with an ankyrin like N-
terminal and C-terminal domain located in the intracellular lumen of bi-layer 
cellular membranes. This channel assemblies as homomeric or heteromeric 
complexes formed by four subunits acted to create the pore of the channel. The 
cation selective pore loop is formed by the fifth and sixth trans-membrane 
domains(S5-pore loop-S6)2.TRPV1as a polymodal receptor can be activated by 
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numerous activators  :  high temperatures(> 43o C),low ph(<6.5) and voltage3,5,6 . 
Endogenous agonists include anandamide, 2-arachidonoylglycerol, N-arachidonoyl 
dopamine, N-oleoyldopamine, ATP, lipoxygenase products and some active 
biolipids such as Lysophosphatidic-acid (LPA) and diacylglycerol (DAG)7,8,. 
Regarding its exogenous ligands, this channel is opened  by capsaicin, the pungent 
ingredient of "hot" chili peppers, resiniferatoxin,  a capsaicin analogue derived 
from the latex of Moroccan "Euphorbia Resinifera"  and some venom toxin3,9,10. 
Given the broad spectrum of activators, TRPV1displays numerous binding sites 
modulating channel opening in the intra and extracellular region as well as 
different regulatory sites. Vanilloid binding site is allocated in the intracellular loop 
at S3(Tyr511),a requisite for anandamide and capsaicin response4. Different 
substitution studies unveil that the replacement of Tyr511 aromatic residue with 
aliphatic or small aliphatic/polar residues decreases or abolishes TRPV1 current 
respectively, and low ph-evoked currents are even maintained 11. These latter are 
attributed to a protonation of aminoacidic residuals present on the extracellular 
loop S5 and S6( Glu600, Glu648) of the channel 12 . On the other hand it has been 
reported that an allosteric modulation of C-terminus  induce a conformational 
change of the protein during temperature increment13. 
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Figure 1: The TRP family tree (Clapman DE. "TRP channels as cellular sensors"  Nature 
2003) 
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1.1 Modulation of TRPV1 by cellular components 
TRPV1 undergoes complex modulation that influences the channel opening or 
gating by extra and intracellular calcium or activation of tyrosine kinase or G-
coupled receptors. These activators, participating to  sensitization and 
desensitization of the channel, the most common feature for TRPV1, could  
influence the channel  activation threshold 5,14, 15,16,17,18.. Indeed , the channel 
being a noxious stimuli detector is modulated by different inflammatory 
mediators released upon physical and chemical damage which interact with their 
coupled receptors. In particular, bradykinin, prostaglandins, nerve growth factor, 
histamine, serotonine or ATP modulate this channel though protein kinase A or C 
(PKA,PKC) dependent phosphorylation on threonine or serine aminoacidic residual 
at different positions 20,21,14.. PKA cascade activation can modulate both 
sensitization and desensitization of TRPV1 channel16,22. While the PKA 
sensitization of heat-evoked TRPV1 response is attributed to Thr144, Thr370and Ser 
502phosphorylation,the PKA-mediated desensitization to anandamide or capsaicin  
occurs on  Ser116 and Thr370 residuals16,22,23. PKC signaling represents another 
element involved in TRPV1 modulatory response,  Ser502 and Ser 800are the 
principal targets of PKC activity24,25,26. Phosphorylation of these two sites is 
responsible of increasingTRPV1 response to its endogenous agonist NADA and 
strongly coupled to capsaicin and heat evoked response27. As sad below, intra and 
extracellular calcium could influence TRPV1 activity. Extracellular calcium 
dependent desensitization of TRPV1 in fact, represents another regulatory 
mechanism involved in the TRPV1 multimodal response5. This mechanism per se 
represents a well-integrated physiological control against calcium  overload in the 
cell. TRPV1 desensitization, involving the channel in a refractory state, is 
fundamental for the setting of sensory neuron activation threshold and for 
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protecting from excessive receptor activation during continuous noxious stimuli 
exposure. Calcium regulation of TRPV1 implicates different players which act in 
different timing. Calcineurin, calcium calmodulin dependent kinase II (CAMKII) and 
calmodulin (CaM) has been described as "actors" involved in this mechanism 
28,2930. Several studies report that calcineurin seems to be coupled with CAMKII in 
the temporal regulation of TRPV1 during its opening/gating states. Probably initial 
calcium influx activates calcineurin first, which dephosphorylates and then 
desensitizes the channel, while CaMKII slowly re-activates and  phosphorylating 
the channel30. On the other hand, the Ca2+-binding protein CaM binds  a 35-aa 
segment of the C terminus of TRPV1 and the disruption of this binding site 
prevents TRPV1 desensitization. However deletion experiments in the presence of 
mutated CaMs or CaMs inhibitors fail to achieve the same effect, suggesting that 
this mechanism might be CaM independent29. All binding and modulator sites are 
summarized  in the Figure 2   
 
Figure 2: TRPV1 structure and principal sites of agonism/modulation 
 
9 
 
1.2 TRPV1 Splicing  
TRPV1s are the results of TRPV1 gene located on chromosome 11 for mice on 17 
for humans. Mouse gene accounts 16 codifying sections (exons) and different 
splice variants. The first published splice variant was identified in 5' in the rat 
mRNA (VR.5'sv)31.  Compared with the full length sequence of the TRPV1, this 
variant is different for two peculiar variations:  1) the expression of a small portion 
of N-terminal part of the protein; 2) the loss of 60 amino acids at N-terminal  
region including a portion of the third N-terminal ankyrin domain. VR.5'sv has 
different genomic origin compared to the full length variant as it uses an 
additional transcriptional starting site at intron IV and encodes for TRPV1-like 
channel with truncated N-terminal domain32. Another splice variant was proposed 
in mice, identical to the full length TRPV1 but with the loss of polipeptide 
sequence encoded by exon 7. Afterwards this variant has been identified as 
TRPV1beta variant in mice (30 nucleotide loss in exon 7 codifying for 10 aa) and 
TRPV1b variant in humans (complete loss of exon 7)33,34. Both mRNA variants 
appear unstable and take particular care to their isolation. Regarding their pattern 
of expression, these variants have been found in peripheral and central nervous 
system. Finally, a cDNA encoding a TRPV1 variant defined as "TRPV1var" has been 
isolated from rat kidney papilla35,36. This variant had a larger mRNA respect to the 
native one but results in a dramatically truncated protein expressing only a part of 
N-ter region and the complete loss of the residual part of the protein.   
Functionally, the resultant proteins act as dominant negative subunit and block 
the activation of their TRPV1 full length "cousins" 37,38  fig.3 .   
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Figure 3:Different TRPV1 proteins resulted from mRNA post-transcriptional 
modification  
A) Full length TRPV1; B) VR.5'sv; C) TRPV1-b(humans) or TRPV1-beta(mice); D) TRPV1var 
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2.TRPV1 localization and functions 
 
Given the polymodal nature of activation of the nociceptor TRPV1, this receptors 
has been deeply characterized in primary sensory neurons. Different techniques 
have been used to investigate the TRPV1 expression pattern. First evidence was 
achieved by using in situ hybridization assay and allocated the TRPV1 as a specific 
nociceptor present exclusively in trigeminal (TG) and  dorsal root sensory ganglia 
(DRG), in particular in a subset of neurons with small or medium size cell bodies 3. 
Subsequent physiological studies defined these capsaicin-responsive cells as the 
unmyelinated C fibers and the small myelinated (A)nerve fibers 40,41 . 
 
2.1 Peripheral structures 
Based on their neurochemical phenotype, small DRG cells has been divided in 
nonpeptidergic isolectinB4(IB4) positive cells responsive to Glial Neurotrophic 
Factor(GDNF) peptidergic IB4 negative cells NGF responsive an positive for 
calcitonine gene-releated peptide (CGRP) and substance P(SP) and small 
myelinated (A)nerve fibers 42,43,44. These classes are defined as capsaicin -
sensitive and TRPV1-immunoreactive in the rat 5,45. 
In the mouse TRPV1 seemed to be prominent expressed in peptidergic ones 
although electrophysiological evidence indicated that also nonpeptidergic cells 
respond to TRPV1 activation 46,47,48. This discrepancy pointed to the need of novel 
genetic approaches to clarify the open question regarding TRPV1 distribution.  
Different "reporter mice" have been created with the purpose to follow TRPV1 
distribution from embryo to adult in many areas 44,49 On the whole, both the 
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amount and expression pattern of TRPV1 positive DRG neurons was age–
dependent.  Compared to DRG, TRPV1 was less abundant in trigeminal ganglia and 
preferentially expressed in peptidergic neurons (73 % CGRP positive and 15% IB4 
positive)44  High number of TRPV1 positive cells have been stained in the Nodose 
Ganglia through in situ hybridization overlapping a profile of expression very 
similar to DRG in terms of density (81% of cells), data undetected by Caterina and 
colleagues in 1997 41,44,50. Tirosin kinase B receptor co-expression is assigned to 
these cells and TRPV1 mRNA signal was completely absent in neurofilament 
positive large cells confirming the more sparse expression of this receptor in 
myelinated cells even in this specific region 41. Moving from DRG and sensory 
ganglia it is possible to find this receptor in various peripheral regions and organs 
such as: nerve terminals in the airways, in the cornea, glabrous and hairy skin of 
the mouse, urinary bladder, ureters and urethra, mucosa, mysenteric ganglia and 
muscular layers of the stomach, the small intestine, and the colon 44,51,52. 
 
2.2 Central Nervous System 
The functional expression of TRPV1 in peripheral structures, especially in primary 
sensory neurons, as well as in the spinal cord, is well established and accepted. On 
the other side, the localization and function of this channel in the brain  is still a 
matter of debate.  
 
2.2a Spinal cord 
Anatomical evidence shows that TRPV1 is expressed in axons, somata and 
dendrites of spinal cord (SC)54,55,56. In the dorsal horn TRPV1 expression involved 
70%  GABAergic  neurons while the occurrence of TRPV1 in non GABAergic 
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neurons is lower (25%). An excitatory/inhibitory balance was described as the key 
of TRPV1 integrative function  of pathological states in the SC. In paticular, the 
functional role of TRPV1 in the SC is associated to the inhibitory control of spinal 
neurotransmission. In fact peripheral signals are integrated  through inhibitory 
control principal excitatory neurons ,56,57. Other electrophysiological studies reveal 
that TRPV1 activation correlates with a decrease of evoked excitatory post-
synaptic currents and an increase of spontaneous inhibitory currents55,58,59. The 
TRPV1 seemed that modulating ascending and descending SC pathways induced 
sensitization or desensitization to somato-sensation and pain influencing  
excitatory and ihibitory neurotransmission at the occurence56.  
 
2.2 b TRPV1 in the Brain 
Many studies shown that capsaicin induce a biological response in different brain 
areas but TRPV1 expression in the brain has been still debated. The use of TRPV1 
genetic approach  defined   "reporter mice" restricted  the presence of this 
receptor in very few areas of the brain with the highest level of expression 
primarily in the hypothalamus60. Different studies failed  to detect the presence of 
TRPV1 mRNA by using in situ hybridization excluding the possibility of its 
functional localization in the brain3,49.  However radiolabeled TRPV1 ligand, RNA 
expression and PCR, western blot and immunoprecipitation identified  the TRPV1 
in the brain of humans, rats and mice 61,62,63 . Specific expression has been 
achieved in major brain areas including cerebellum, cortex, hippocampus, dentate 
gyrus, amygdala, habenula, hypotalamus, suprachiasmatic nucleus, inferior olive,  
substantia nigra and others61,64,54,65,66,67,68,69 These results have been  further 
confirmed by variegated  functional evidence. The capsaicin application on acute 
brain slices induce  pre and post-synaptic response in different brain areas  as well 
as change in temperature induce an TRPV1-mediated inward rectifying current  
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onto supraoptic hypotalamic vasopressine containing neurons 70.  The systemic 
capsaicin treatment lead  the capability to bind silver salts(positive to 
neurotoxicity capsaicine-mediated) throughout the whole rat neuraxis 71.Different 
autoradiography  studies with specific binding of  [3H]Resinferatoxin  revealed 
positive results for the presence of this channel in widespread  brain and capsaicin 
application induced the expression of immediate early gene C-fos in 
Amygdala66,67. In Mezey E. et al. 2000 is reported a positive immunoreactivity for  
trpv1 in rat and human different brain areas including all cortical areas, 
hippocampus ,amygdala and lower brainstem (cerebellum, locus coeruleus, 
nucleus of solitary tract, nucleus of trigeminal nerve, cochlear nuclei). Recent 
electron microscopy studies detected  the presence on TRPV1 in molecular layer 
of dentate gyrus mostly localized in postsynaptic dendritic spines and in CA1cell 
body of pyramidal neurons in the stratum piramidale and into perisomatic 
gabaergic  synapses73,74. However in Lee et al. 2015 the majority of gold particles 
representing the subcellular position of TRPV1 was found to be attached to 
intracellular membrane cisternae and have not plasma membrane localization . 
The subcellular compartment of the remaining  gold particles  are not described 
and  all away from the plasma membrane. Regarding mRNA controversy there are 
several works that found TRPV1 -mRNA positive staining by using an antisense 
probe for in situ hybridization and real time-PCR  in different brain regions 
including cortical and hippocampal regions 61,75. The messenger RNA profile of  
TRPV1 expression appeared stable  at different time point during the lifespan  of 
mice excluding the possibility of a developmental decrease of expression as 
described  in Cavanaugh et al.2011.  
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3. TRPV1 function in the brain 
 
Most of the studies on brain TRPV1 showed that this channel acted  as a 
modulator of neurotransmission. Exogenous TRPV1 activation by capsaicin 
mediated  an enhancement of neurotransmitter release and for this reason was 
often principally reported as causative pre-synaptic protein. At excitatory 
synapses of substantia nigra capsaicin and/or N-Arachidonoyl dopamine (NADA) 
facilitated  spontaneous excitatory  post synaptic currents (EPSCs) frequency 
consistent with a presynaptic site of action and a TRPV1-mediated increase of 
glutamate release indirectly enhanced  the firing rate of ventral tegmental area 
dopaminergic neurons76,77,78. The same presynaptic effect  is reported in Locus 
Coeruleus adrenergic neurons79. The enhancement of synaptic transmission 
TRPV1-mediated has been attributed  to Ca2+ increase in pre-synaptic terminals 
via activation of voltage-gated Ca2+ channels. Acute slice of medial preoptic 
nucleus  the hypotalamus even  revealed  that  capsaicin increases both excitatory 
and inhibitory post-synaptic currents frequency80,81. In the other hand,  patch 
clamp experiments described TRPV1 as post-synaptic player. In TRPV1 is described 
as functional postsynaptic protein. An heat ramp (from 25 to 39 degrees) induces 
experimentally in hypothalamic vasopressin containing neurons a causative 
increase of the firing rate and an inward rectifying current, directly associated to 
TRPV1 activation 83.Both effects, in fact  have been abolished in TRPV1 knockout 
mice. As post-synaptic "actor" the TRPV1 was also described as synaptic plasticity 
modulator. A separate paragraph  discuss this activity below.  
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3.1 TRPV1-dependent synaptic plasticity 
 
The TRPV1 is a high calcium permeable channel very similar to NMDA receptor in 
terms of calcium permeability. For this reasons  was described as a great 
candidate for calcium-dependent synaptic plasticity. TRPV1modulation of synaptic 
plasticity was firstly reported in hippocampus, when the amount of  LTP in TRPV1 -
/- mouse was significantly reduced compared to WT mice 84 . Subsequent studies 
report TRPV1 receptor as mediator of  synaptic plasticity in  postsynaptic 
compartment. TRPV1modulated Long Term Depression (LTD)  was reported in 
dentate gyrus by promoting calcineurin dependent α-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid (AMPA) receptor internalization increasing the  calcium 
influx 85. Other forms of synaptic plasticity has been described as post-synaptic 
effect of TRPV1. In the Nucleus Accumbens, anandamide , produced during high 
frequency post synaptic stimulation, induced a form of LTD modulated by both 
pre-synaptic CB1 and postsynaptic TRPV1. This cannabinoid-mediated LTD results 
in a reduction in neurotransmitter release Cannabinoid receptor 1-dependent and 
a in a TRPV1-mediated postsynaptic AMPA internalization86. Another form of 
TRPV1-dependent LTD has been reported in the bed nucleus of stria terminalis in 
which postsynaptic  TRPV1  are activated by anandamide synthesized and 
released upon post-synaptic metabotropic glutamate receptor activation 87.  A 
peculiar  pre-synaptic LTD is reported as TRPV1 dependent. In this mechanism the 
TRPV1-mediated reduction of glutamate release from pyramidal cell induces a  
LTD in perisomatic interneurons 82. In conclusion  TRPV1 in cooperation with other 
receptors has been reported in other forms of synaptic plasticity, underlining the 
importance of this channel in the synaptic strength shaping the functional 
organization  of brain circuits 88. 
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4.Microglia 
Microglia cells are defined as the immune-competent resident cells of CNS 89 . This 
group of cells was firstly described by Pio del Rio-Hortega during his visionary 
period of activity that represent the corner stone of current microglial studies 
(fig4). He  hypothesized  that these cells are derived from circulating mononuclear 
cells with mesodermal origins  that differentiate in the brain as mature branched 
microglia 89. Actually, it is a common point of view that microglia originates from 
bone marrow. However two separated population of microglial precursors cells 
have been described  : the first derived from progenitors with 
myeloyd/mesenchymal origin, the second depicts a transient and developmental 
form of fetal macrophage strictly related to amoeboid microglial population 
described in post-natal brain of mammals 90. The main idea is that microglial cells 
exist as a stable population in the brain and have a very low turnover 91,92 .It is 
possible however that during  pathological condition, circulating monocytes 
should invade the brain and a line of bone marrow-derived cells could replace 
until 50% of microglia in postnatal period 93,94. Supporting this , it is reported that 
blood monocytes could differentiate in mature microglia in "astrocyte conditioned 
medium"95.The morphological maturation in ramified microglia from immature 
blood monocytes should be due to different cytokines released by astrocytes. 
Neutralizing antibodies against transforming growth factor beta, macrophage 
colony-stimulating factor and granulocyte/macrophage colony stimulating factor 
added to "astrocyte conditioned medium" prevent this maturation process 96. 
Generally microglia is classified according to its morphological phenotype: resting 
microglia, activated microglia and ameboid phagocyting microglia. In CNS 
however, is appreciable a "provincially adapted microglia" which is guided and 
shaped following  the structural organization of the tissue and different 
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biochemical signals97,98,99 .Physiologically, these immuno-competent cells of CNS 
are prepared to answer to different aversive signals(i.e. biochemical or infective 
stimuli) and their response is related to the perceived stimulus. In vivo two 
photon imaging shows that microglial processes and arborizations continuously 
monitored brain parenchyma every few hours carrying out a sub-form of 
homeostatic surveillance100 .According to its condition, microglia should be found 
in three different phenotypes based on the environmental  circumstance in which 
was involved . The resting/surveillant microglia, a polarized pro-inflammatory 
phenotype defined as M1, prominent during a cytotoxic response mediated by 
infective pathogens or during tissutal active phagocytosis and cell migration and a 
different phenotype, M2,  assumed  when microglia is involved in resolutive 
processes acting to protect the tissue from damage and promote differentiation 
of oligodendrocyte progenitor through the release of anti-inflammatory cytokines 
101,102.  Experimentally, M1 or M2 phenotypes should be reproduced by inducing 
particular conditions in the extracellular milieu. The addition of the toll-like-
receptor (TLR)-4 agonist (lipopolysaccharide; LPS), interferon (IFN)-γ, IL-17A, 
orTNF-α promotes the M1 pro-inflammatory phenotype. Conversely , stimuli such 
as IL-4, IL-10, IL-13, transforming growth factor (TGF)-β and/or glucocorticoids 
induce a state of immunological regulation or alternatively, an activated 
phenotype (M2)101,102  (Fig5) .  The M1/ M2 paradigm has been increasingly studied 
in different pathologies in an attempt to uncover mechanisms of immune-
pathogenesis. Understanding the molecular and functional states of microglia 
provides a framework to dissect out and interrogate both beneficial and harmful 
roles of these cells. 
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Figure 4:Images of ramified microglia discovered by Del Rio Ortega 1919 (Bol. de la Soc 
esp de biol 1919)  
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Figure 5 A schematic view of microglia activation.  
Resting microglia in the presence of LPS or IFN-γ polarize in M1 pro-inflammatory 
phenotype. In contrast "good signals" such as IL-4 or IL-13 induce M2 protective 
phenotype. IL-10 production is an anti-inflammatory signal which down-regulates M1 
function (Adapted from Nakagawa Y. and Chiba K. Pharmaceuticals 2014)  .  
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4.1 Microglia currents 
Most of the functional studies on microglia cells have been performed  in vitro and 
in  ex vivo  conditions in which microglial cells are already moderately activated. 
So far, there are not electrophysiological evidences of microglial cells basal 
properties (resting membrane potential, membrane currents or measurement of 
intracellular calcium homeostasis) in vivo. These cells are characterized by high 
input resistance and very low resting membrane potential ex vivo (mean -20mV) 
103.The membrane conductance mainly consisted of delayed rectifying outward 
and inward currents ,accomplished by potassium channels, could be influenced by 
receptors already presents on microglia104,105,106. Recent evidence reports 
spontaneous microglia currents recorded from satellite cells (microglia that is in 
strictly contact to neuronal membrane) associated to the potassium and chloride 
reversal potential . These currents could be thus mediated by a cationic 
conductance, presumably sodium or calcium, or by a mixed cationic 
conductance107.  
 
4.2 Microglia "off-label" functions  
 
4.2a Synaptic pruning 
Excluding their principal function in the brain, as resident immuno-competent 
cells, microglia  are highly motile cells in physiological and in pathological 
conditions100. During these movements is reported a very frequent and transient 
contact with the synapses 108,109 .These "contacts" have been described as crucial 
for brain development in early post natal period in rodents 110 .The key of this 
developmental  mechanism was found in the selective increase of the chemokine 
fractalkine on the neuronal surface. This chemokine , whose receptor  in the CNS 
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are a  selective privilege of microglial cells, is reported as a "find-me" message 
during neuronal development in synapses in which occur phagocytosis111,112,113. 
The selective loss of neuron to microglia fractalkine signaling in early post natal 
period, as reported in the fractalkine receptor  knock out mice model,  increases  
excitatory dendritic spines as in an immature synapses110 .These particular 
function of microglia is strategic  for normal brain maturation and is reported as 
strictly important in development of a normal social behavior in mice 114 .  
 
4.2b Microglia modulation of neurotransmission  
Microglia communicate with neurons and astrocytes by direct physical contact as 
well as by releasing several soluble and insoluble mediators through classical or 
atypical secretory pathways 100,115. In fact, imaging studies reveal  that microglia 
dynamically interact with synapses responding to changes in neuronal activity and 
neurotransmitter release. Emerging studies indicate that activated microglia could  
influence both the synaptic neurotransmission and synaptic plasticity, laying the 
foundations for a quad-partite synapses. The acute stimulation of microglial cells 
by LPS modulates hippocampal excitatory synaptic neurotransmission through the 
activation of purinergic receptors on astrocytes 116. Also in vitro model of 
combined both inflammation-hypoxia, describes a novel form of LTD in which 
microglia mediate AMPA receptor internalization  in acute slices of hippocampus 
117.Other studies underline an atypical  microglia to neuron communication 
through the release of small signaling vesicles or exosomes  defined " 
microvesicles"  released  upon microglia stimulation through  i.e. purinergic or toll 
like 4 receptors 118.  Acute application of these exosomes on cultured neurons 
significantly increases GABA and glutamate release by influencing the sphingolipid 
metabolism and synaptic activity on pre-synaptic terminals 119,120,121 .Take 
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together these data underlie a growing evidence of microglia modulation of 
synaptic neurotransmission.   
4.3 TRPV1channel on microglia 
There are different direct or indirect  evidences collected  in vitro or in ex vivo 
experiments demonstrating  the expression of several TRP channels on microglia. 
Primary rat cultured microglial cells express TRPV1 mRNA as demonstrated by RT-
PCR and TRPV1 inhibition in cultured BV2-microglial cells seems  to reduce oxigen 
species  production and phagocytosis 122,123,124.In the other hand, in the rat retina, 
elevated hydrostatic pressure induces an increase of microglial IL-6 release and 
cytosolic TNF-alpha a phenomenon that is partially inhibited by 5-
Iodoresiniferatoxin (5-IRTX)  a specific antagonist of TRPV1125. Other ex in vivo 
experiments describe a strongTRPV1-dependent microglia damage in mice 
Substantia Nigra 122. Altogether these data represent only indirect evidence on the 
functional expression of TRPV1 in microglia cells. Moreover, most of them have 
been obtained from cultured primary microglia or microglia-like cells in which the 
gene and consequently the protein expression can be altered. 
 
 
5. Pain 
The pain is an unpleasant sensorial and emotional experience which acts to 
preserve the organism against potential tissue damage. This protective 
mechanism should  become chronic or debilitating when an eventual tissue 
damage persist or when in particular conditions the lesion has healed and the pain 
is continuously felt. Pain sensation is the result of the activation of peripheral 
nociceptive primary sensory neurons126.  Nociceptors innervate the peripheral and 
deep tissues as well as the internal organs and detect a broad range of noxious 
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mechanical, thermal and chemical stimuli integrated in polimodal fashion. After a 
damage, the affected area  undergoes a series of plastic changes resulting in a 
temporary sensitization of the afferent sensory fibers. In fact persistent pain 
associated with a peripheral injury results in an alteration of peripheral nerves 
properties and production of an inflammatory response, characterized by the 
release of cytokines, prostaglandins, neurotrophic factors, chemokines, lipids, 
peptides, ATP and glutamate. This inflammatory soup together with non neuronal 
cell infiltration and the persistent activation of inflammatory receptors 
characterizes the phenomenon called peripheral sensitization127. This 
hyperactivity give rise to phenomena defined allodynia (when normally innocuous 
stimulus is perceived as painful) and hyperalgesia (when normal pain stimulus 
elicit pain of great intensity). The pain experience initiated  in the  periphery  
should be maintained by both peripheral and in central loci. in fact, a deregulation 
of peripheral or central ways involved in pain can lead to physiologically and 
emotionally debilitating disease.  
 
5.1 Anatomical overview  
 
Peripheral sensory feelings are detected through nociceptors. The cell bodies of 
nociceptors are located in the DRG for the body and TG for the face. Nociceptors 
have a unique morphology in which central and peripheral terminals derive from a 
common axonal stalk and for this reason are called pseudo-unipolar neurons. 
Peripheral and central axonal branches innervate target organs and SC 
respectively. A single stimulus or a sum of stimuli  that are recognized as noxious 
activate these neurons  modifing  the threshold of activation of these fibers 
underline  the great capability of response that characterize the polymodal 
nociceptors128. There are two major classes of nociceptors: small-medium 
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diameter myelinated A-delta fibers and small diameter unmyelinated C fibers. The 
first fibers  are involved in the  the rapid/ acute pain and second in the integration 
of  slow pain response  (Meyer et al. 2008).The non-noxious sensory detection is 
leaved to A-beta larger diameter fast  fibers.   The A-delta class is subdivided in 
two principal classes: i) type I-high threshold nociceptors, responsive to 
mechanical and chemical noxious stimuli and characterized by high heat threshold 
(>50oC) and ii) type II A-deltafibers, responsive to low threshold heat and for very 
high threshold mechanical stimuli. In the other side, the unmyelinated C fibers are 
very heterogeneous 129. C fibers  include a population which is susceptible to both 
heat and mechanical stimulus  as well as a population heat-responsive but 
mechanically insensible (silent-nociceptors)  activated only after an injury 130 
.Primary afferent nociceptor  fibers project to the dorsal horn of the SC. The SC is 
organized anatomically in distinct laminae (ten laminae). The dorsal horn involve 
the first five 131. The A-delta fibers project to lamina I and to deeper lamina V; the  
A-beta fibers project in deep laminae III,IV and V. The C slow fibers terminate in 
lamina I and into the most dorsal and mid-region parts of the lamina II. 
Anatomical and electrophysiological studies have shown that SC neurons of 
lamina I and II are principally involved into noxious response, lamina III and IV are 
primary involved in innocuous stimuli detection and neurons in lamina V receive 
noxious and non-noxious  inputs 128. The major input of SC to the brain is 
constituted by lamina I and V projecting fibers126. Multiple afferent pathways , in 
particular the spino-thalamic and spino-reticulo-thalamic tracts, represent  the 
pain ascending fibers to the thalamus and brainstem; both reach and integrate in 
cortical structures.  In the supraspinal structures , there is not a single brain area 
essential for pain sensation,  but a cooperative group of structures involved in 
sensory or emotional integration of pain defined the "pain matrix"132,133.. Different 
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central areas are activated during noxious  integration. In humans as well as in 
rodents, brain areas activated during pain experience are the somatosensory 
cortex 1, somatosensory cortex 2, anterior cingulate cortex (ACC), insula, 
prefrontal cortex, thalamus and cerebellum134 . Other studies report also the 
amygdala and nucleus accumbens as nociceptive structures receiving  input from 
the spinoparabrachial tract or spinoreticular-periacqueductal grey pathways 
135,136,137,138. The somatosensory cortices encode information  in terms of sensory 
features, location and the duration of pain139,140. The ACC and Insula represent the 
most important areas encoding the emotional and motivational aspect of pain in 
humans and rodent 141,142,143 .The descending pain pathway represent the 
antinociceptive route or the "filter" controlling  the pain felt. . The most 
frequently studied modulatory descending  pathway involve the periacquedudctal 
brainstem nuclei, rostroventral medulla, locus coeruleus and the spinal cord . 
Stimulation of  the descending pathway induces analgesia and involves 
endogenous opioids and catecholamines, namely noradrenaline and serotonin, 
which in turn control ascending projections and alter the pain perception144 
(fig.6). 
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Figure 6:Semplified  ascending and descending pain pathway  
Pain signals arrive in the DRG which integrate in the dorsal horn of the spinal cord. Spino-
thalamic and spinoreticular-thalamic afferents integrate in the thalamus. Sensory 
information arrive in the thalamus which  in turn integrate in cortices (somatosensory 
cortex 1, somatosensory cortex 2, anterior cingulate cortex (ACC), insula, prefrontal 
cortex) and in limbic areas (not shown in the figure). Periaqueductal grey matter receives 
descending  fibers from cortices and limbic areas. Descending pathway is involved in    
control of ascending pathway. 
 
5.2 Neuropathic pain 
Neuropathic pain (NP) is a form of chronic pain involving a broad spectrum of 
conditions associated with a lesion or disease of the peripheral or central somato-
sensory system. Its prevalence in the general population may be as high as 7–8% 
and account 20-35 % of chronic pain 145,146. The major cause of NP might be find in 
the lack of normal homeostatic reparative process of peripheral o central nervous 
system lesions. Conversely, the secondary forms, in terms of causal occurrence, 
are associated to a primary syndrome such as diabetes, primary oncological pain 
and secondary pain due to pharmacological treatment of tumors and genetics. 
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Central syndrome accont 8% of patients and occur after stroke, spinal cord injury 
and multiple sclerosis 147,148,149 .This NP syndrome acquires importance because of 
a very low rate of successful pharmacological treatments. The clinical symptoms 
are frequently characterized by continuous and evoked pain sensation, an 
allodynic and hyperalgesic syndrome in which  normal non noxious sensory 
mechanical or thermal sensation triggers intense pain 150. The emotional-cognitive 
sphere is usually  strongly compromised and induce an aberrant behavioral 
response in terms of pain perception defined "central syndrome" (anxiety ,stress 
,sleep deprivation etc.). This cognitive  syndrome exacerbates, in the subject 
affected , the real perception of  pain . So, we can define the "pain syndrome" a 
sum  of these two part: an emotional-central somatization and a peripheral 
painful sensation151,152,153,154.  
 
5.3 Central supra-spinal  sensitization  
Persistent pain appears to be mediated by plastic changes and/or central 
sensitization, particularly in the pain matrix. The medial thalamus is the principal 
relay station of nociceptive input to the anterior cingulate and prefrontal cortices. 
The persistent stimulation of this pathway by pain during peripheral tissues 
injuries influence  neurons excitability in the neocortex 155,156,157 . In particular the 
persistent pain is associated with long-term changes in the morphology, 
neurochemistry, and gene expression in the anterior cingulate cortex, which 
contribute to the maintenance and exacerbation of pain 158. This brain region in 
fact, is deputed to  the strict coupling between sensory and emotional component 
in humans as well as in mammals. The  ACC, in fact  is a key cortical region 
involved in pain integration 159,160,161 . The ACC is divided in  different layers of 
pyramidal cells and local interneurons  (fig.7). Principal  pyramidal cells are 
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located in layers II, III and V. Principal sensory input arises from the thalamus in 
the layer II-III. Output projections of the ACC, pyramidal cells are located in deep 
layer V which project to sensory related brain areas, including the motor cortex, 
amygdala, midbrain areas, brainstem and spinal cord (Fig.8). Several plastic 
changes involve specific input and output regions  during chronic pain condition in 
this area . The re-enforce and central  sensitization during chronic pain occur  as  
synaptic strengthening  in ACC in pre- and in post-synaptic manner influencing the 
neurotransmitter release and increasing receptor balance in post-synaptic 
compartment exacerbating the "pain syndrome" 160,162. 
 
Figure 7: Anterior Cingulate cortex organization 
A modified copy of Cajal's  drawing of ACC. It is evident the typical layers subdivision of cortical 
areas. Layer II and III contain small soma pyramidal cells and interneurons. The dimensions of the 
soma is larger in pyramidal cells of the layer V. The branches of the pyramidal cells of  the layer II-III 
and V extend to layer I.   
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Figure 8: A schematic rapresentation of pain-related  input and output in ACC  
 (red) Simpified circuitry of ACC.The thalamic and cortical (blue )excitatory input  reaches the layer 
II and III of ACC. After the integrative process layer V of ACC  communicate to output areas 
influencing descendig pathways of pain.The ACC projections to the amygdala are involved in 
emotional response to adversive events. Inter and intracellular cortical connections are frequently 
reported.  
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5.4 TRPV1 and pain 
As reported above, TRPV1 is reported as the  key in the peripheral sensory 
transmission but also a synaptic player whose activation modulates 
neurotransmitter release and synaptic plasticity. The TRPV1 role in pain 
perception and exacerbation assumes a predominant role when this receptor 
undergoes long-term modifications such as its sensitization. Robust 
hypersensitivity to heat is a clinical feature of chronic neuropathic pain and TRPV1 
is a key component of thermal hyperalgesia mediated by 
inflammation163,164.Indeed TRPV1 can be strongly activated by components of 
inflammatory soup in peripheral and in central nervous system such as bioactive 
lipids, extracellular protons ATP, NGF and bradykinin which influence the 
activation threshold of TRPV1. In CNS has been shown that activation of 
postsynaptic  spinal TRPV1decreased functional AMPA receptor expression in 
interneurons of substantia gelatinosa and thus reduced excitation of these 
neurons. Moreover, GABAergicTRPV1 reduced inhibitory synaptic signaling to 
spino-thalamic neurons suggesting a mechanism of disinhibition of spinal cord 
projection neurons that are critical for the relay of nociceptive signals to higher 
brain centers55. At brain level the functional role of TRPV1 has been well 
characterized in the modulation of descending nociceptive pathway , in particular 
the periacqueductal-rostroventral-medulla circuit 165. The activation of TRPV1s in 
the ventral lateral periacqueductalgrey (vlPAG) induces an  anti-nociceptive effect 
by activating the glutamatergic cells in the rostral ventral medulla (RVM) and 
inducing a firing decrease in these pronociceptive cells166.Conversly, capsaicin 
injection in the dorsolateral PAG induces pronociceptive effect167. Other works 
underline the importance of TRPV1 in the modulation of descending midbrain 
path. Mallet and collegues reported that acetaminophen metabolites N-(4-
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hydroxyphenyl)-5Z,8Z,11Z,14Z -eicosatetraenamide as well as  paracetamol 
metabolites (arvanil and olvanil)  is capable to activate TRPV1 in the PAG inducing 
an antinociceptive effect in a formalin tail immersion model of pain. This effect is 
completely lost in Fatty amine idrolase(FAAH) an in TRPV1 knockout mice 168,169 
Furthermore,the role of TRPV1 on pain matrix goes beyond the PAG-RVM circuits. 
The TRPV1 activity is reported in other areas that participate to pain integration 
such as the ACC, locus coeruleous and medial prefrontal cortex79,170,171,172. In these 
areas, TRPV1 activation induces an increase rather a decrease of glutamatergic 
neurotransmission and seems to contribute to persistent pain condition171.Other 
studies performed in pre/intra limbic cortices suggest that TRPV1 activation is 
involved, as in ACC, in the processing of the affective pain component. Inhibition 
of TRPV1 in these areas  reduced the pain behavioral response in a model of spinal 
nerve injury 172. All these data underlining , as suggested in this study, a strong 
cortical TRPV1-dependent control on painful events.  
 
 
 
 
 
 
 
 
 
33 
 
Aim of the study 
Since its discovery, the role of TRPV1 in the brain has not been clearly assessed. 
Moreover, compelling evidence indicate that TRPV1 has a highly restricted brain 
distribution. Conversely, numerous studies underlie that indeed TRPV1 is 
functional in different brain regions by acting both as postsynaptic mediator of 
different forms of synaptic plasticity and modulator of neurotransmitter release 
by a presynaptic mechanism. However, the immunohistochemical evidence does 
not support this latter effect. Considering the anatomical versus functional 
discrepancies on TRPV1, the objective of my thesis is to give more insights on the 
role of this channel in the brain in both physiological and pathological conditions 
i.e neuropathic pain. Among the painmatrix brain areas, this study focuses on the 
ACC to investigate the TRPV1 cellular mechanisms on the regulation of the 
emotional pain aspects. 
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CHAPTER 2 :METHODS 
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Animals 
Both adult (P80-120) and young (P20-30), C57BL/6 (Charles River Laboratories, 
Como, Italy) and B6.129S4-Trpv1tm1Jul/J mice (TRPV1-/-; The Jackson Laboratory, 
Bar Harbor) were used in the present study. CX3CR1+/GFP male mice (P18-30) from 
D. Ragozzino (university of Sapienza, in Rome) were employed in this study. 
 
Behaviour 
Testing conditions and chronic constriction injury 
All animals were housed in standard cages and kept under a 12-hour light-dark 
cycle in an air-conditioned facility. Following the procedure originally proposed by 
Bennett and Xie (1988), adapted for mice, chronic constriction injury of the sciatic 
nerve (CCI) was used as murine model of neuropathic pain. As previously 
described68, CCI was obtained by three unilateral ligatures of sciatic nerve. In the 
following, injured and uninjured hindpaws are indicated as ipsilateral and 
contralateral hindpaws with respect to the sciatic nerve ligation. Anesthesia was 
performed intraperitoneally with zoletil (tiletamine and zolazepam, 100 mg/ml, 
0.5 ml/kg) and rompun (xylazine, 20 mg/ml, 0.5 ml/kg). 
All mice were examined for mechanical allodynia at days 3, 5, 7, 10, 12, 14, 17, 19, 
21, 31 post-CCI. The behavioral analysis was conducted in the morning, and 
experimental procedure was in blind.  
For ex vivo and in vitro experiments, mice were sacrificed at different time points 
after CCI and the assessment of allodynia development. For adults, we used the 
following time table: three days, one or four weeks after CCI, while young mice 
were sacrificed at three days, one or two weeks after CCI. In particular, for adults 
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the mechanical threshold (force-grams) was measured in naive and CCI at day 3 
(DF1,19; F 83,02; P<0,0001), 7 (DF 1,19; F 118,19; P<0,0001) and 21 (DF 1,19; F 28,05; 
P< 0,0001) after neuropathy induction.  
As control, we used mice that underwent surgery without the sciatic nerve 
ligature (sham animals) and naïve animals, which did not undergo to any surgery. 
Both in vivo and in vitro data obtained from naïve and shams were pooled since 
no differences have been observed. 
Mechanical allodynia 
This parameter was assessed by measuring withdrawal threshold of both 
hindpaws to normally non-noxious punctuate mechanical stimuli by using an 
automatic von Frey apparatus (Dynamic Plantar Aesthesiometer, Ugo Basile, 
Comerio, Italy). After a 5 min of adaptation to the apparatus, the mechanical 
stimulus was applied to the midplantar surface of both hindpaws68. The 
mechanical threshold was measured as the maximal force (expressed in grams) at 
which mice withdrew its hindpaw. At each testing day, withdrawal threshold were 
taken as mean of three consecutive measurements with 10-s interval between 
each measurement. 
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Development of allodynia after CCI .Mechanical threshold (force-grams) was measured 
in naive (no CCI, n=10) and CCI mice (n=11) at 3 (D3; DF1,19; F 83,02; p<0.0001), 7 (D7; 
DF 1,19; F 118,19; p<0.0001) and 21 days (D21; DF 1,19; F 28,05; p< 0.0001) after 
neuropathy induction. 
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Electrophysiological recordings 
From neurons 
Both naïve/sham and CCI adult C57BL6 and TRPV1 KO mice were deeply 
anesthetized with isofluorane inhalation, decapitated, and brains removed and 
immersed in cold “cutting” solution (4°C) containing (in mM): 126 choline, 11 
glucose, 26 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 10 MgSO4, 0.5 CaCl2 equilibrate with 
95% O2 and 5% CO2. Coronal slices (300 µm) were cut with a vibratome (Leica) and 
then incubated in oxygenated artificial cerebrospinal fluid (ACSF) containing (in 
mM): 126 NaCl, 26 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 2 MgSO4, 2 CaCl2 and 10 
glucose; pH 7.4, initially at 32°C for one hour, and subsequently at room 
temperature, before being transferred to the recording chamber and maintained 
at 32C. Recordings were obtained from visually identified pyramidal neurons in 
layer 2/3, easily distinguished by the presence of an emerging apical dendrite. 
Experiments were performed in the whole-cell configuration of the patch-clamp 
technique. Electrodes (tip resistance = 3-4 MΩ) were filled with an intracellular 
solution containing (in mM): Kgluconate 135, KCl 4, NaCl 2, HEPES 10, EGTA 4, 
MgATP 4 NaGTP 2; pH adjusted to 7.3 with KOH; 290 mOsm. Whole-cell voltage-
clamp recordings (-70 mV holding potential) were obtained using a Muticlamp 
700B (Axon CNS, Molecular Device). Spontaneous EPSCs recorded in the presence 
of TTX 1M (mEPSCs) were filtered at 1 kHz, digitized at 10 kHz, and recorded on 
computer using Digidata1440A and pClamp10 software (Molecular Device). Series 
resistances were not compensated to maintain the highest possible signal  to 
noise and were monitored throughout the experiment. Recordings were discarded 
if Rs changed 25% of its initial value. Experiments in voltage-clamp recording were 
carried out in the presence of GABAA receptor antagonist picrotoxin (100M) and 
TTX (1M). Spontaneous events were detected and analyzed with Clampfit 10.4 
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using amplitude and area thresholds set as a multiple (3–4X) of the SD of the 
noise. Each event was also visually inspected to prevent noise disturbance of the 
analysis. The cumulative amplitude and interevent plots obtained for each cell in 
controls and after drug application were compared using the Kolmogorov–
Smirnov (KS) test.  
Each slice received only a single exposure to capsaicin or to other agonists. In 
experiments performed to investigate a postsynaptic TRPV1-mediated response, 
the ionotropic glutamate receptor blockers 6,7-dinitroquinoxaline-2,3,dione 
(DNQX, 10 μM) and DL-2-amino-5-posphonovaleric acid (DL-APV, 50 μM) and the 
GABAA receptor antagonist picrotoxin (100M) were included in the bath 
solutions. For voltage-clamp experiments TTX were also added.  
For current-clamp experiments membrane resistance was measured from 
responses to current injections (-60 pA, 250 ms, 0.2 Hz) and were performed in 
the presence of ionotropic glutamatergic and GABAA receptor antagonists.  
 
From microglia cells 
Acute slice of cingulate cortex (cG1 and cG2) was prepared from CX3CR1+/GFP male 
mice (P18-30). Animals were decapitated under halothane anesthesia, and whole 
brains were rapidly immersed for 10 min in chilled standard artificial cerebrospinal 
fluid (ACSF) containing (in mM): NaCl 125, KCl 2.3, CaCl2 2, MgCl2 1, NaHPO4 1, 
NaHCO3 26 and glucose 10 (Sigma Aldrich). The ACSF was continuously 
oxygenated with 95% O2, 5% CO2 to maintain physiological pH. Coronal 250 mm 
cingulate cortex slices were cut at 4 °C with a vibratome (DSK, Kyoto, Japan) and 
placed in a chamber containing oxygenated ACSF to recover for at least 1 hour at 
room temperature. 
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All recordings were performed on slices submerged in warmed ACSF (30-32 °C) 
and perfused (1 ml/min) with the same solution in the recording chamber under 
the microscope. 
Visually identified GFP-expressing microglial cells were patched in whole-cell 
configuration in the cingulate cortex. Micropipettes (4–5 MΩ) were usually filled 
with solution containing the following composition (in mM): KCl 140, EGTA 0.5, 
MgCl2 2, HEPES 10, and Mg-ATP 2 (pH 7.3 adjusted with KOH, osmolarity 290 
mOsm; Sigma Aldrich). Voltage-clamp recordings were performed using an 
Axopatch 200A amplifier (Molecular Devices). Currents were filtered at 2 kHz, 
digitized (10 kHz) and collected using Clampex 10 (Molecular Devices); the analysis 
was performed off-line using Clampfit 10 (Molecular Devices). Slicing procedure 
might activate microglial cells especially near the surface of the slice, whereby 
recordings were performed on deep cells. The current/voltage (I/V) relationship of 
each cell was determined applying ramp protocol from -120 to +50 mV in 500 
msec every 10-30 seconds after whole-cell configuration was achieved (HP = -70 
mV between steps). Resting membrane potential and membrane capacitance 
were measured at start of recording. 
Capsaicin was first dissolved in DMSO and then in ACSF solution at a final 
concentration of 1 M and applied in bath for 10 minutes. 
 
Histology and immunofluorescence 
From fixed sections of cortex, spinal cord and dorsal root ganglion 
Both young (P21-24) and adult (P80-90) naïve and CCI C57BL6J/ Trpv1-/- mice 
were sacrificed with lethal dose of carbon dioxide and immediately underwent 
perfusion procedure. Blood was firstly transcardially washed out with cold 
phosphate buffer 0.9% saline solution (PBS), and tissues were fixed by cold 4% 
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paraphormaldehyde in 0.1 M pH 7.4 phosphate buffer (PB) with a peristaltic 
pump. Brains and spinal cords were dissected, postfixed for 18-22 hours at 4°C, 
washed from paraphormaldehyde with PB and cryoprotected in 30% sucrose/PB 
at 4°C. 
Dry ice frozen brains were cut into 40 μm coronal sections with a cryostat 
microtome (Leica Microsystems) at -20°C, including anterior cingulated cortex 
(ACC, Fig 22- 28 of mouse brain atlas, Franklin e Paxinos, 2001). Frozen lumbar 
spinal cord (L4-L5) was cut into 40 μm sections. Dorsal root ganglia were dissected 
from not perfused animals, fixed by 4% paraphormaldehyde solution, 
cryoprotected in sucrose solution and cut in 30 μm sections. 
Sections were rinsed for tree time in PB and incubated with a mix of primary 
antibodies in PB 0.3% Triton X-100 (Applichem, BioChemica, Darmstadt, Germany) 
overnight at room temperature. Primary antibody incubation step was followed 
by three 10-min rinses in PB at RT. Afterwards, sections were incubated for 2 h at 
RT in a mix of secondary antibodies, followed by three 10-min rinses in PB. DAPI 
was applied for 5 minutes in the second rinse, dissolved in PB solution.  
To exclude non-specific signals of secondary antibodies, sections from each group 
of animals have also been stained with secondary antibody alone, following the 
same experimental procedure but omitting the primary antibodies. 
 
From freshly acute cortical slices 
Adult (P80-90) C57BL6 and B6.129S4-Trpv1tm1Jul/J (TRPV1-/-) mice were sacrificed 
after anesthesia with isoflurane and the brain was immediately dissected. 300 m 
thickness coronal slices containing ACC were cut with a vibratome (Leica 
Microsystems) in oxygenated ACSF. Slices were then kept at 32°C in a submerged 
chamber containing ACSF equilibrated with a mixture of 5% CO2 and 95% O2. For 
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the pharmacological treatments, slices were transferred in a submerged chamber 
containing ACSF (control), ACSF plus DMSO (vehicle), capsaicin (1 M) or LPS 
(500ng/ml) for 10 minutes (same time as used for electrophysiological recordings) 
and immediately after, fixed in 4% paraphormaldehyde ,0.1 M phosphate buffer 
(PB) for 2 h at room temperature. After the fixing, slices were cryoprotected in 
30% sucrose/PB and resectioned into 40 μm coronal sections with a cryostat 
microtome, following the same procedure as for fixed slices.  
 
Antibodies 
The following primary antibodies were used: rabbit anti-TRPV1 (1:100, 
Immunological Sciences Rome, Italy), mouse anti-TRPV1 (1:100, Millipore 
Bioscience Research Reagents, USA ), rabbit anti-TRPV1 (1:500, Neuromics, Edina, 
MN), rabbit or mouse anti-NeuN (1:1000, Millipore Bioscience Research Reagents, 
USA), rabbit anti-GFAP (1:500, DakoCytomation, Glostrup, Denmark), rabbit anti-
Iba1 (1:500, Wako, Osaka, Japan), rat anti--CD11b (1:300, Serotec; Kidlington, UK), 
goat anti Glutamate Transporter (EAAC1, 1:100, Millipore Bioscience Research 
Reagents, USA ). For nuclear staining, 4,6’ diamidino2-phenylindole 
dihydrochloride (DAPI,1:2000, Life Technologies, Carlsbad, California) was used. 
Secondary Cy3, DyLight488 and DyLight 649-conjugated antibodies were used 
(1:200, Jackson ImmunoResearch, West Grove, PA, USA). 
 
Acquisition and analysis of images 
Double-immunofluorescence and triple-fluorescence labeling was examined with 
a confocal laser scanning microscope (Leica SP5, Leica Microsystems, Wetzlar, 
Germany) equipped with four laser lines: violet diode emitting at 405 nm, argon 
emitting at 488 nm, and helium/neon emitting at 543 nm and 633. Confocal 
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images were acquired through the 40x/63x objective at the 1 zoom factor. In the 
case of magnifications, zoom factor was raised in order to focus only on the area 
of interest.  
Points of colocalization were supposed when a merging area in the same cell was 
evident, showing a yellow resulting colour from the overlap of two green-red 
signals, and they were verified by magnifications and analysis on the z axes with 1-
2 microns stacks. 
Quantitative data from images were obtained keeping the following imagine 
acquisition criteria: 40x objective, 1024 x 1024 frame, 10 hz acquisition frequency, 
pinhole 1 airy unit, lasers at 50%.  
For analysis of the area occupied by the signal, confocal acquisitions of ACC for 
each hemisphere were taken comprehending area covered by the 40x objective in 
both naïve and mice suffering from neuropathic pain (two for ipsilateral and two 
for contralateral ACC), in order to have an overview of the first cortical layers 
(layers 2-3), and a second acquisition including the more internal layers (layer 
five). Since there were no significant differences between medial and internal 
layers (measured for each couple of layers for any group, t Test p › 0.05), 
quantifications were cumulated so as to obtain an evaluation of the antibody 
expression in the whole ACC. 
Each image has been analyzed with Image J free software (National Institutes of 
Health, US; http://imagej.nih.gov/) with the following procedure: for each single 
image the background was subtracted in a same proportion for each group, in a 
range between 10%-50% on respect to the specific antibody. Images were 
reduced at 8 bit from the original RGB acquisition and a threshold was established 
in order to obtain a digital image where neither original signal disappeared and 
nor new signal was created. These images were analyzed with the command 
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“analysis of particles”, setting a filter in order to the size of signal and measuring 
in micrometers. Data were expressed as Area Fraction, the percentage of the total 
image area covered by the measured object. To establish the percentage of 
neurons expressing TRPV1, or both TRPV1 and EAAC1 marker, images in double 
and triple staining were acquired. Cells immunopositive for NeuN, TRPV1 and 
EAAC1 were counted, in the merging images, by the use of non-automatic cell 
counting method (Leica Microsystems software). Data are presented as the 
percentage of means. 
Colocalization was intended as two proteins that occupy the same volume of 
interest.  
The amount of colocalization was evaluated by using the Pearson statistical index 
of correlation (r) between two variables. This analysis describes the effect size as 
the strength of the linear correlation between the two variables (Evans, 1996: 0-
0.19 “very weak”, 0.20-0.39 “weak”, 0.40-0.59 “moderate”, 0.60-0.79 “strong”, 0. 
80-1.0 “very strong”).  
For colocalization analysis, a double fluorescence image (red and green dyes) was 
splitted in RedGreenBlu channels. Background was subtracted from the red and 
the green channels (8 bit each) and they were analyzed for correlation using the 
colocalization plugin with Pearson and Manders index. Pearson index was chosen 
for its consistency and lack of sensibility to the picture background.  
For each colocalization analysis, 256×256 Red-green scatterplots were generated 
by the Image J program: the intensity of red pixels is used as the x-coordinate 
whereas the intensity of the green pixels as the y-coordinate. 
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Morphometric analyses 
Morphometric analysis were performed on a high resolution imagine acquisition 
criteria: 40x objective, 2048 x 2048 frame, 200 hz acquisition frequency 3X 
average scan, pinhole 1 airy unit, lasers at 50%.  
Although two 40x objective confocal acquisitions were acquired in order to obtain 
an overview of ACC (one for cortex layers 2/3 and one for layer five) only the first 
layers acquisition (L2/3) was chosen for morphometrical analysis.  
Each image has been analyzed with plugin “Shape descriptor 1u” of Image J 
software (http://imagej.nih.gov/plugins) with the following procedure: images 
were reduced at 8 bit from the original RGB acquisition and a threshold was 
established in order to obtain a digital image where neither the original signal 
disappeared and nor new signal was created. The plugin setting was fixed at a 
minimum of 200 μm of size and analysis was performed automatically on cell 
silhouettes. 
Transformation index (TI) was used as an index of microglia morphology 69,70 and 
calculated by the equation: [perimeter of cell (μm)]2/4Π [cell area (μm²)]. Since TI 
is dependent on cell shape but independent of cell size, this latter crucial for the 
identification of the three different microglia activation states (bushy, 
ipertrophied and ameboid), we exploit this parameter in order to obtain an 
unbiased analyses and avoid negative falses. The area:TI ratio was calculated for 
each cell and a scale value was set to obtain 4 group of cells (Suppl Figures7A): 
RESTING cells (values of area:TI ranging from 1 to 25); HYPERTROPHIED cells 
(values of area/TI ranging from 25 to 35); BUSHY cells (values of area/TI ranging 
from 35 to 60); AMEBOID cells (values of area/TI  up of 60). The percentage of cell 
ratio was calculated by dividing the number of a specific cell group (i.e. resting, 
bushy, hypertrophied and amoeboid) for the total cell number of each 
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experimental condition (control, vehicle, capsaicin/lps, in both wt and TRPV1 -/- 
tissue).The frequency of cells in each category was statistically quantified by the 
using of Fisher's exact test and performed on raw data. 
 
Western Blotting 
Western blotting was performed according to standard procedures. Briefly, 
isolated tissues (10 mg) and cells (3x105) were resuspended in lysis buffer (50 mM 
Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM MgCl2, 1 mM EGTA, 1% (v/v) Nonidet P-40, 
10 μg/ml aprotinin, 10 μg/ml leupeptin, 1 mM PMSF), homogenized with a glass-
Teflon homogenizer and/or sonicated prior to centrifugation. Proteins in the 
lysates were quantified by the Bradford assay kit (Bio-Rad, Hercules, CA), 
separated by SDS-PAGE (10%) and transferred to nitrocellulose membranes. Blots 
were then incubated with primary antibodies recognizing TRPV1 (diluted 1:1000), 
NeuN (diluted 1:500), Iba1 (1:500), or actin (diluted 1:100000). After incubation 
with the appropriate horseradish peroxidase-conjugated antibody, blots were 
developed using an enhanced chemiluminescence detection system (Luminata 
Crescendo Western HRP substrate, Merck Millipore, Darmstadt, Germany). 
Scanning densitometry on the developed film was conducted at 600 dpi using a 
CanoScan LiDE 210 (Canon, Tokyo, Japan) and analyzed using Image J 1.49v 
program (http://imagej.nih.gov/ij). 
Isolation of Neuronal and Microglial cells and Flow cytometry analysis 
Cerebral cortex from 12 C57Bl6J and 3 TRPV1-/- mice (60-70 days old) were 
dissociated to single-cell suspension by enzymatic degradation using neural tissue 
dissociation kit from MACS® Technology (Miltenyi Biotec) according to the 
manufacturer’s protocol. Briefly, cortical tissues were weighed before mincing, a 
pre-warmed enzyme (Papain) mix added to the tissue pieces, and incubated under 
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slow, continuous rotation at 37 °C on a MACSMix Tube Rotator. The tissue was 
further mechanically dissociated by trituration and the suspension was applied to 
a 70-micron cell strainer. Myelin was removed using Myelin Removal Beads II kit 
on autoMACS Pro Separator. Cells were processed immediately for MACS 
MicroBead separations. In order to separate primary microglia, The CD11b-
positive cells were magnetically labeled with CD11b (Microglia) MicroBeads and 
isolated on autoMACS Pro Separator. The negative fraction was further processed 
with Neuron Isolation kit by depletion of non-neuronal cells and neurons were 
obtained from the unlabeled cells running through autoMACS Pro Separator. Both 
cells populations were fixed with 4% paraformaldehyde (PFA) for 10 minutes and 
then stained first with mouse primary TRPV1 antibody and then with anti-mouse 
Alexa633 secondary antibody. Subsequently neuronal cells were stained with 
mouse primary antibody NeuN and then with anti-mouse Alexa488 secondary 
antibody, while microglial cells with PE-Cy7-conjugated CD11b. For microglial 
activation experiments, 2X105 cells were left untreated or stimulated with 
Capsaicin (1 μM) for 10 minutes, washed and then left in complete medium in 
presence of Brefeldin A (10 μg/ml) in order to block cytokine exocytosis. At the 
end of the incubation, cells were stained at the cell surface with CD11b, fixed with 
4% PFA for 10 minutes, and then stained intracellularly with APC-conjugated TNF-
α and PE-conjugated IL-10 antibodies in 0.5% saponin for 20 minutes. Cells were 
acquired using FACSCyan ADP (Beckman Coulter) flow cytometer and analyzed 
using Flowjo software (TreeStar, Ashland, OR).  
Microglia cell cultures  
Primary cultures of cortical glial cells were obtained from 2-day-old C57BL6 mice 
and killed by decapitation according to Directive 2010/63/EU and as describe 
in Levi et al. 1984.  Cells were plated at low density (3 × 106 cells per 90-mm dish) 
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and cultured in basal Eagle's medium (BME), supplemented with 10% heat-
inactivated fetal calf serum (FCS) and 5 mM KCl for 20 days. Microglial cells were 
obtained by dish gentle shaking, collected by centrifugation and reseeded71. This 
protocol produced cultures with > 90% microglial cells, as verified by 
immunofluorescence with monoclonal antibodies for the specific markers ED1 and 
iba1. 
 
Quantification of EVs 
Nanosight measurement. Microglia were exposed to serum free culture medium 
for 10 minutes, in order to quantify constitutive EV production. The medium was 
collected, the cells kept for about 5h in complete medium, and then re-exposed to 
serum free medium added with 300 nM capsaicin or 1mM ATP (positive control) 
for 10 min, to measure EV production upon TRPV1 stimulation. Conditioned media 
were pre-cleared from cells and debris at 300g for 10 min (twice) and the number 
and dimension of MVs and exosomes were analyzed with Nanosight LM10-HS 
system configured with a 405 nm laser and EMCDD camera (Hamamatsu 
Photonics). Videos were collected and analysed using the NTA-software (version 
2.3), with the minimal expected particle size, minimum track length, and blur 
setting, all set to automatic. Camera shutter speed was fixed at 20.01 ms and 
camera gain was set to 350. Ambient temperature was ranging from 25 to 28° C.  
Five recordings of 30 seconds were performed for each sample. EV production 
under capsaicin exposure was normalized to constitutive EV release from the 
same Petri dishes, to minimize possible variability in the density of donor 
microglia. 
Spectrophotometric quantification of shed MVs. Microglia were incubated with 
5M NBD-C6_HPC, washed with Kreb’s Ringer solution, and stimulated with ATP 
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or capsaicin. Supernatants were collected, centrifuged 10 min 300g 4°C to remove 
cells and debris, and then total fluorescence was assayed at 463/536 nm with a 
Tecan Infinite500 spectrophotometric system (Tecan, Group Ltd, Switzerland). 
Constitutive or evoked MV shedding was quantified from at least three distinct 
Petri/condition in each experiment. 
 
qRT-PCR. 
Total RNA was extracted by previously isolated mouse neurons and microglial 
cellsas well as from spinal cord, using ReliaprepTM RNA Cell Miniprep System 
(Promega). cDNA reverse transcription was performed by means of Superscript 
VILO cDNA Synthesis Kit (ThermoFisher Scientific), according to manufacturer 
instructionsas reported (Chiurchiù et al., 2014 Atherosclerosis).The following 
program was used for the quantitative RT-PCR: 25 °C for 10 min, 42 °C for 50 min, 
85 °C for 5 min, then after addition of 0.1 unit/ml of Escherichia coli RNase H, the 
product was incubated at 37 °C for 20 min. The target transcripts within the ECS 
were amplified by means of an ABI PRISM 7700 sequence detector system 
(Applied Biosystems, Foster City, CA), using the following specific primers 
forTRPV1 and β-actin: mouse TRPV1 F1 (5’-CATCCTCCTGCTCAACATGC-3’) and R1 
(5’-GCCTTCCTCATGCACTTCAG-3’) and mouse β-actinF1 (5’-
TGTTACCAACTGGGACGA-3’) and R1 (5’-GTCTCAAACATGATCTGGGTC-3’). All assays 
were performed in duplicate, and for each well we used 10ng of sample template 
cDNA. Assays were run on Roche Lightcycler 480 Real-Time PCR System. 20 μl 
assays were prepared for each sample as it follows: 5 μl of cDNA product,10μl of 
SYBR Green master mix (Roche, cat # 04707516001), 2 μl of each primer (4 μM, 
Sigma) and 3 μl of PCR-grade water.The following PCR program was used: 5 min of 
pre-incubation at 95 °C, followed by 40 amplification cycles at 95 °C for 10 s, 61 °C 
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for 20 s, and 72 °C for 7 s.All data were obtained using automatic detection of 
TRPV1 gene Ct normalized with β-actin; for each sample, TRPV1relative expression 
was evaluated as fold increase of gene expression compared withβ-actin (2^ΔCt, 
with ΔCt= Ct (TPRV1) –Ct (β-actin)).The specificity of PCR reactions was evaluated 
at the end of each experiment by analyzing melting curves for each sample and, 
later, by running the assays in a 2% agarose gel. 
 
Statistics 
 
The sample number  for electrophysiological experiments have been  calculated 
on the basis of for previous experiment. All data were expressed as means ± 
S.E.M. For immunofluorescence experiments, significance was tested using one-
way ANOVA followed by a Tuckey post hoc test for internal significance or student 
T test in the case of two groups comparisons. For electrophysiological data, 
Shapiro-Wilk test was exploited to verify a normally distributed data population. 
We then applied parametric or non-parametric tests. For the former, we used 
ANOVA and Student t Test. For non-parametric data we used Wilcoxon Signed 
Rank test (paired samples) and Mann-Whitney test and Kolmogorov Smirnov test 
(unpaired samples).Statistical differences were considered as significant at p<0.05. 
Statistical analysis was performed by using Origin 8.1 software (OriginLab 
Corporation). 
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CHAPTER 3 : 
RESULTS AND DISCUSSION 
 
 
 
 
 
 
 
51 
 
TRPV1 is expressed in microglia of ACC and other supraspinal pain areas  
Our immunohistochemical evidence achieved by using a TRPV1-monoclonal 
antibody shows that this antibody stain fibers in ACC sections of adult mice (n=16 
from 9 mice; Fig. 9a,b). The antibody specificity was tested in tissue samples from 
TRPV1-/- mice (n=8 from 6 mice).The polyclonal antibodies, in this experimental 
conditions,  continue to stain cytoplasm of cells in tissues of TRPV1-/- mice, this 
nonspecific stain is completely absent by using the anti-TRPV1 monoclonal 
antibody (Fig.10). Double immunofluorescence for TRPV1 and the neuronal 
marker NeuN showed that the TRPV1 positive fiber principally surrounded 
neuronal bodies (Fig. 9a, n=5 from 4 adult mice). Sparse overlapping between the 
two antibodies was evident in confocal maximum projection (Fig. 9a, TRPV1/NeuN 
panel). However single 1-2 m z-stacks showed that merged signal is not the 
result of a neuronal staining but could be attributed to the slight overlap of TRPV1 
fibres surrounding neurons. The amount of colocalization between TRPV1 and 
NeuN was “very weak” as indicated by the Pearson coefficient of correlation (PCC; 
r=0.125 ±0.012, n=5 from 4 mice; Fig. 9 . Double immunostaining with the anti-
TRPV1 MAb and the microglial marker Iba1 revealed that TRPV1 was mostly 
expressed in microglia (Fig. 9b) as confirmed by the high grade of colocalization of 
TRPV1 and Iba1 signals (r=0.720 ±0.010, n= 5 from 5 mice, Fig. 9 d).This  microglial 
TRPV1 expression pattern was also evident in other “painmatrix” areas i.e 
somatosensory cortex, dentate gyrus, thalamus and periaqueductal gray (PAG) 
 ( Figure 11). In order to confirm this pattern of expression and our hypothesis, 
analyses on highly purified neurons and microglial cells from cortical adult tissues 
were performed. Protein analysis evaluated by flow cytometry revealed low mean 
fluorescence intensity levels of surface TRPV1 expression in NeuN positive 
neurons (MFI=48.2±7.4, n= 3 from 3 mice pools), whereas CD11b positive 
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microglial cells showed intense levels (MFI=124.8±15.2, n= 3 from 3 mice pools) 
(Fig. 12 a-b). These findings were further confirmed through western blot analysis 
on protein extracts of ACC and postnatal cortical microglia cultures. TRPV1 was 
immunodetected as a band of 100 kD in the ACC extracts from wild-type but not 
from TRPV1 -/- mice (fig.12 c). We also detected a second band of 75 kDa that was 
still present in TRPV1 -/- tissues and was absent in cultured microglia cells (non 
specific band) (Fig. 12 d). 
This evidence can also be observed when comparing TRPV1 expression in the ACC 
vs  cortical microglia cultures, whereby this receptor was 6-fold higher in the latter 
cells (fig12 e). Finally, in order to verify that such highly expressed TRPV1 on 
microglial cells was also fully functional, we performed patch-clamp recordings of 
CX3CR1-GFP expressing microglial cells from ACC slices upon application of 
capsaicin. As expected and consistent with the typical properties of TRPV1 
channels, we observed the activation of a capsaicin-evoked outward rectifying 
current (Fig. 12.g), suggesting that functional TRPV1 is present in the microglia of 
mouse cortex. The differences  in TRPV1 protein expression is independent  from 
TRPV1 mRNA synthesis. Acute isolated cortical neurons and microglial cells 
express similar amount of TRPV1 protein( fig. 12f )  
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Figure 9 . TRPV1 protein expression in microglial and neuronal cells of the ACC of adult and 
young naïve mice. (a) Photomicrograph of double immunofluorescence for anti-TRPV1 MAb 
(green) and NeuN (magenta). The anti-TRPV1 MAb labels mainly fibers surround neurons (NeuN 
positive cells) and different type of cells (yellow arrows) .(b) Anti-TRPV1 positive processes highly 
overlap with the microglial marker iba1 (in red) in the layer 2/3 of ACC. (a,b) DAPI, nuclear marker 
(in blue)  .  (c,d) Graphic representation (scatter plot) of the correlation coefficient of Pearson 
(PCC) for quantifying the colocalization  between the anti-TRPV1 and NeuN (in yellow, PCC=0.13) 
and anti-TRPV1 and Iba-1 (PCC=0.77). Note that higher PCC values correspond to a strong 
colocalization (Evans, J. M. Straightforward Statistics for the Behavioral Sciences. (1996). 
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Figure10:TRPV1-MAb antibody validation. High resolution confocal laser scanning 
photomicrographs of ACC sections wt  and TRPV1-/- mice , showing the staining pattern of three 
different anti-TRPV1 antibodies (Abs). (a) Anti-TRPV1 MAb labeling of fibers (Millipore Chemicon, 
1:100). Same protocol of immunostaining on TRPV1-/- mice tissues shows no stain from both 
primary or secondary antibody (b-c) The cell cytoplasm or whole-cell body labelling of two anti-
TRPV1 pAbs is similar in cortical tissues from wt and -/- mice. 
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Figure 11:(a-d) Confocal laser scanning photomicrographs of somatosensory cortex (SS 
n=17/9),dentate gyrus (DG n=17/9), thalamus (THAL n=17/9) and periaqueductal gray 
(PAGn=11/6) showing labeling for anti-TRPV1, Iba-1 and their merged. Like the ACC, also in these 
brain regions the TRPV1 is mainly expressed in the microglia. 
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Figure 12 
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Figure 12 TRPV1 protein is mainly expressed on microglial cell and is functional active 
Neuronal and microglial cells were isolated from cortical tissue using specific magnetically labeled 
kits. According to physical parameters, obtained cells were gated on NeuN and CD11b for 
identification of neurons (a) and microglial cells (b) respectively. Surface expression of TRPV1 was 
analyzed by means of flow cytometry. Data are representative of a single experiment and show 
the mean fluorescence intensity (MFI) of 3 independent pools of at least 3 mice. (c) Representative 
immunoblot of TRPV1 expression in ACC fromwild-type (wt) and TRPV1-/- (-/-) mice. Protein lysate 
of each tissue was subjected to immunoblotting following SDS-10% PAGE against the anti-TRPV1 
monoclonal antibody. The bottom portion of the nitrocellulose membranes was probed with the 
anti–actin antibody, as loading control. N.S.: non specific band. Note that this band is still present 
in tissue from TRPV1-/- mice. (d) Representative immunoblots comparing the TRPV1 content in 
ACC (50 μg) and microglial cells (6 μg). Microglial cells isolated from mice were lysed and subjected 
to immunoblotting against the anti-TRPV1 antibody. Note that N.S. band is absent in microglia cell 
cultures. Due to a strong difference in relative abundance of actin in the protein extracts of ACC 
tissues and isolated microglial cells, the enrichment in TRPV1 expression was assessed by 
normalizing optical density values for the Ponceau staining of total proteins. Particularly, optical 
density values were internally normalized by Ponceau  staining of total protein content and further 
corrected for the value of ACC considered equal to 1.. ìThe purity of microglial cultures was 
assessed by assessing specific markers for neurons (NeuN) and microglia cells (Iba1). (e)Histograms 
of TRPV1 expression od normalized TRPV1 in ACC against microglial cultures *p<0.05 f) RT-PCR of 
TRPV1 gene expression cortical neurons (white bar) and microglial cells (dark gray bar) isolated 
from C57BL6J mice: for each sample, TRPV1 threshold cycle was normalized to that of β-actin. Data 
are expressed as mean±SD and are representative of two independent pools of mouse cortices (4 
mice/pool) p=0.27  Student t-test). (g) Left, Current-voltage relationship of the capsaicin-induced 
current by application of capsaicin 1μM in a microglial cell from acute cortical slice of 
CX3CR1+/GFP mouse before (black curve), during (red curve) and after (blue curve) capsaicin 
application; Middle, capsaicin induces an outward rectifying current with reversal potential at 
about 0 mV (results obtained by subtracting the current before and after the capsaicin 
application). Right, time plot of the mean current amplitude at +50 mV (n=9). The arrow indicate 3-
9 minutes of capsaicin application.  
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TRPV1 is expressed on astrocytes processes of ACC and hippocampus 
The anti-TRPV1 MAb also labeled astrocytes of the ACC (n=3 from 3 mice, Figure 
13a), although its expression was significantly lower than in microglial cells 
(r=0.720 ±0.010 and r =0.291 ±0.011, for microglia and astrocytes, respectively, 
p<0.01; Two Sample t-Test). Since GFAP positive cells in the ACC were very scarce, 
the hippocampus has been chosen as comparison area to avoid an 
underestimation of TRPV1 in astrocytes (Figure 13b).  Despite the wider 
population of GFAP positive cells, a low degree of TRPV1-GFAP colocalization was 
also detected in hippocampus  (r=0.344 ±0.016 n=3 from 3 mice; (Figure 13c,d). 
 
 
 
Figure 13:  TRPV1 expression on GFAP+ cells : a comparison between ACC and Hip  
(a,c) Representative photographs of anti-TRPV1 staining in GFAP positive astrocytes of ACC (left 
panels) and hippocampus (HIPPO; right panels). GFAP staining in the hippocampus is higher than in 
cortex. (b,d) Correlative color scatter plots of TRPV1(green) and GFAP (red) from the experiments 
reported in a and c respectively. In yellow, the colocalization (merged) of the two antibodies (ACC 
r= 0.30, Hippor=0.36). 
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TRPV1 m-Ab stains principally  GCRP peptidergic  neurons in DRG 
To test the effective quality of TRPV1-mAb we decided to assess the TRPV1 
staining in DRG, a region in which TRPV1 profile of expression has been broadly 
described. The TRPV1 positive(TRPV1+) cells in this area (n=8 observations n=7 
mice ) was 67,11% of NeuN positive cells, TRPV1 signal was completely absent in 
DRG of TRPV1 ko mice (fig.14b) We tested a subset of neuronal markers to 
identify the nature of TRPV1+ cells. The markers used were the following: 
CGRP(for peptidergic cells), IB4( for not peptidergic cells) and NF200 (for 
myelinated A-b cells). As already reported in other studies most of the TRPV1+ 
cells are CGRP positive (34,62%) (fig.15a). The remaining TRPV1+ cells are 
identified as immunopositive for IB4 (13.57%) and NF200(12.92%) corroborating 
already reported literature regarding the  principal  expression of TRPV1 on 
peptidergic fibers 46,47,48 (fig.15b-c).  
 
Figure 14: TRPV1- MAb stain DRG NeuN positive cells in WT mice (a)TRPV1 MAb signal is present 
NeuN positive cells in DRG of WT mice. (b) TRPV1 MAb signal is absent in the TRPV1 -/- DRG 
confirming the specificity of the antibody. 
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Figure 15:  TRPV1 is mainly expressed in CGRP positive DRG neurons (a)TRPV1-MAb co-localizes 
abundantly  with CGRP positive cells. (b-c) TRPV1 is partially expressed in IB4 positive (non 
peptidergic) and NF200 positive (myelinated) cells  
 
TRPV1 channels are expressed in cortical neurons of mice suffering from 
neuropathic pain 
Our new evidence on TRPV1 localization in brain microglia. However is supposed 
that neuronal expression of this channel is induced by exacerbated pathological 
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conditions as chronic pain. This common idea suggest us to assess the expression 
pattern of this channel in the ACC of adult mice suffering from neuropathic pain at 
different time points from the ligature of the sciatic nerve (chronic constriction 
injury, CCI). Three days after the nerve constriction, TRPV1 was still expressed in 
cortical microglia similarly to sham- mice (n=7 from 3 mice; Fig. 16 ). One week 
after CCI, anti-TRPV1 MAb started to stain also the cytoplasm and the apical 
dendrite of Iba1-negative cells, whose morphology resembled neurons (n=7 
experiments, 5 mice; Fig. 16 a-h), and this immuno-reactivity pattern was limited 
to layer 2/3 of both hemispheres and was less marked in the ispilateral than the 
contralateral hemisphere. At 4 weeks after CCI, the cytoplasmic expression of 
TRPV1 in Iba1-negative cells was broadly distributed throughout all layers of the 
contralateral hemisphere (Fig. 16p; n=19, 7 mice). In line with these observations, 
TRPV1 microglial expression decreased in the contralateral ACC of 1 week and 4 
week CCI mice. Indeed, the Pearson correlation coefficient for anti-TRPV1/Iba1 
signal colocalization was weaker in the contralateral ACC of 1 week and 4 week 
CCI mice compared to ispilateral cortices (Fig. 16 q-t). This evidence was 
corroborated by a double immunofluorescence staining with NeuN and anti-
TRPV1 that revealed TRPV1 expression in both cytoplasm and branches of NeuN-
positive neurons (n=7 from 3 mice; Fig. 17 a), thus suggesting that TRPV1 was also 
expressed in cortical neurons upon induction of neuropathic pain. In particular, by 
adding to the immunostaining EAAC1, the neuronal glutamate transporter marker, 
we also showed that TRPV1 was mostly expressed in pyramidal neurons. Indeed, 
whereas almost all EAAC1 immunopositive neurons expressed TRPV1 (Fig. 17b), 
only a small fraction of EAAC1 negative neurons were immunoreactive for TRPV1 
(n=3 from 3 mice). The neuronal expression pattern was prominent in ACC, 
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although other areas such as the thalamus, somatosensory (ss) cortex, PAG and 
hippocampus sporadically displayed TRPV1 expression in neurons .  
 
 
 
 
Figure 16: TRPV1 distribution pattern in the ACC of CCI adult mice. Beyond microglia cells (iba-1 
positive, in red), the anti-TRPV1 MAb stains both the cytoplasm and apical processes of some iba1 
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immunonegative cells ( white arrows in the INSET). This expression pattern was minor in the 
superficial cortical layers of the ipsilateral (IPSI; a-d) than contralateral (CONTRA, e-h) hemisphere 
of mice that underwent surgery from 1 week (1W CCI mice). In 4-week CCI mice (i-l, m-p), when 
the chronicization of pain becomes established, the anti-TRPV1 MAb labels both cytoplasm and 
apical processes of iba1 negative cells (green) of the CONTRA hemisphere (o,p). Note that this 
staining pattern is also present in the deeper layers of the ACC (o) while is absent in the IPSI 
hemisphere of 4W CCI mice (k,l). (INSET) High-power views of cells from the box areas in all 
merged panels. (q-t) Color scatter plots representing the amount of colocalization (yellow) 
between the anti-TRPV1 (green) and iba-1 (red) in each condition. Smaller PCC values denote a 
higher expression of TRPV1 in the cytoplasm of iba1-immunonegative cells.  
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Figure 17 :TRPV1 is also expressed in principal neurons of the ACC from CCI adult mice 
Contralateral ACC photomicrographs of    4 weeks CCI mice, from two independent experiments 
(a,b). (a) Anti-TRPV1 MAb labels both the cytoplasm and the apical dendrite of NeuN positive cells. 
The remnant TRPV1 positive fibers and cytoplasms probably belong to glial cells (yellow arrows). 
(b) Anti-TRPV1 MAb labels EAAC1 positive neurons and NeuN negative cells (yellow arrow) 
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Microglial TRPV1 stimulation tunes cortical glutamatergic neurotransmission  
Growing evidence shows that activation of brain microglia modulates excitatory 
neurotransmission and increases synaptic strength116,117,173. Given our data on 
TRPV1 expression in brain microglia, we hypothesized that the well-characterized 
presynaptic modulation of neurotransmission by TRPV1 is achieved  by  direct 
stimulation of TRPV1 on microglia.  
To address this possibility we first explored the action of TRPV1 stimulation in the 
ACC. As reported for other brain areas, capsaicin () selectively increases the 
frequency of miniature excitatory postsynaptic currents (mEPSCs) onto PNs of ACC 
without affecting their amplitude (Fig. 18 a) suggesting a pre-synaptic mechanism 
of action. Both pharmacological blockade through the non-competitive antagonist 
IRTX and genetic deletion of TRPV1 inhibited the enhancement of mEPSC 
frequency by capsaicin (Fig. 18 b). The TRPV1 effect on neurotransmission is 
mediated downstream by AMPA receptors on post-synaptic compartment. In fact  
bath application of the non NMDA receptors antagonist, 6,7-dinitroquinoxaline-
2,3-dione (DNQX, 20 μM) completely abolished both frequency and amplitude of 
mEPSCs and in this experimental conditions capsaicin increased neither frequency 
nor amplitude of mEPSCs (Fig. 19). Assessed this , in order to demonstrate that 
such TRPV1-induced modulation of pre-synaptic neurotransmission was mediated 
by microglial cells, we activated TRPV1 in the presence of the microglial inhibitor 
minocycline. The application of  minocycline per se (100nM) did not affect basal 
mEPSCs (from 2.34±0.59 to 2.28±0.66 Hz, p=0.85 and from 19.54±1.49 to 
19.29±1.62 pA, p=0.82; n=9), and strongly counteract the capsaicin-induced 
increase of mEPSC rate (Fig. 20 a-c) suggesting that the enhancement of 
glutamatergic neurotransmission by capsaicin is due to the activation of TRPV1 
expressed by microglia cells. We found, while in a low amount,  a partial 
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expression of TRPV1 on GFAP positive cells. To exclude a possible role of 
astrocytes in such microglia-neuron communication upon TRPV1 activation, patch-
clamp  recordings were performed also incubating the slice with the astroglial-
specific toxin fluoroacetate (FAc 1 mM) 116 .As expected, capsaicin still enhanced 
mEPSCs rate (Fig 20  d,e), suggesting that at least in this experimental conditions 
astrocytes are irrelevant for the TRPV1-mediated microglia-to-neuron 
communication.  
 
 
Figure 18: TRPV1 activation increases mEPSCs frequency  onto pyramidal neurons of the ACC. (a)  
Left, example traces of AMPAR mEPSCs recorded from a PN at -70 mV, in control and after 1 M 
capsaicin (caps), in the presence of picrotoxin (100M). Below trace shows expanded trace 
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recording during caps. Middle, cumulative distributions of mEPSC interevent interval (IEI) and 
amplitude from cell shown on the left (p<0.02 and p=0.32 respectively). Right, summary 
histograms and line series plots of mEPSC frequency and amplitude showing that capsaicin 
significantly increases the frequency but not the amplitude of mEPSCs (from 3.40±0.71 to 
4.83±0.84 Hz, n=12, p < 0.001; from 15.97±1.13 to 15.90±1.60 pA, n=12, p=0.83). Data are values 
from single cells (black filled circle) and mean + SEM. (b) Group data of mEPSC frequency and 
amplitude showing the lack of effect of capsaicin in the presence of the TRPV1 antagonist IRTX 
(left; from 6.46±0.68 to 5.88±0.50 Hz, n=8, p=0.11) or in cortical tissue from TRPV1-/- mice (right; 
6.84±1.15 to 6.81±1.20 Hz, n=12, p=0.9). 
 
 
 
 
Figure 19: Bath application of the non NMDA receptors antagonist, 6,7-dinitroquinoxaline-2,3-
dione (DNQX, 20 μM) completely abolished both frequency and amplitude of mEPSCs (from 
6.45+/-1.09 Hz to 0.38 +/- 0.11 Hz, n= 6,paired T-test p= <0.001; from 16.79+/-0.80 pA to 0.88+/-
0.18 pA, n=6, paired t test p= <0.001). In these conditions, capsaicin increased neither frequency 
nor amplitude of mEPSCs, suggesting that downstream TRPV1 signalling is AMPA receptor 
mediated. The NMDA component was excluded in this type of experiments. 
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Figure 20: Microglial TRPV1 modulates synaptic neurotransmission  (a) Example recording of 
mEPSCs before (left) and during (right) capsaicin in the presence of 100 nM minocycline and 10 M 
picrotoxin. (b) Cumulative probability plots comparing minocycline (black line) and minocycline 
plus capsaicin (red line) on mEPSC interevent interval (IEI) and amplitude of the recording showed 
above (p=0.25 and p=0.31, KS test). (c) Bar histograms of group data showing the lack of capsaicin-
mediated increase of mEPSC rate when microglia activation is blocked by minocycline (from 
3.98±0.35 to 4.13±0.33 Hz, n=9, p=0.53; from 17.54±0.94 to 17.34±0.79 pA, n=9, p=0.70, Paired 
Sample t-Test). Group data are presented as single value and mean+S.E.M. (d) Example recording 
of mEPSCs before (left) and during (right) capsaicin in the presence of 1mM fluoroacetate (FAc) 
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and 10 M picrotoxin. (e) Cumulative probability plots comparing FAc (black line) and minocycline 
plus capsaicin (red line) on mEPSC interevent interval (IEI) and amplitude of the recording showed 
above (p<0.01 and p=0.28, KS test). (f) Summary data of both mEPSC frequency and amplitude 
recorded in the presence of FAc before and during capsaicin application (FAc 5.30±0.72 Hz, 
FAc+caps 6.70±1.10 Hz, *p<0.05 Paired t-test; FAc 18.58±1.55 pA, FAc+caps 18.63±1.98 pA, n=7, 
p=0.89 Paired Sample t-Test). 
 
Glutamate metabotropic receptors are not involved in microglia to neuron 
communication on pre-synaptic terminal 
Different studies reported that glial cells induce an increase of neurotransmitter 
release activating metabotropic receptors of glutamate on pre-synaptic terminals 
receptors116,174 .To investigate a possible involvement of these receptors in the 
presynaptic modulation of glutamatergic transmission upon TRPV1 activation, 
capsaicin was applied with the mGluR5 antagonist MPEP (50M) or with the non-
selective group I mGluR antagonist MCPG suggesting that mGluR are not involved 
in the upstream TRPV1 signalling.Both MEP and MCPG did not induce changes in 
basal synaptic properties  (Fig21 a-b) 
Figure 21: Cortical pre-synaptic metabotropic receptors are not invonved in microglia capsaicin-
mediated pre-synaptic effect on excitatory neurotransmission .Capsaicin was applied with the 
mGluR5 antagonist MPEP (50M) or with the non-selective group I mGluR antagonist MCPG 
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(100M) (a-b). In both assays capsaicin significantly increased mEPSC frequency (from 7.96+/-1.11 
to 9.27 +/-0.89,n=7, p= 0.040 paired sample T-test; from 6.67 +/- 0.71 to 8.039+/-1.14385, n=8, 
p=0.042 paired sample T-test), suggesting that mGluR are not involved in the upstream TRPV1 
signalling.Both MPEP and MCPG did not induce changes in basal synaptic properties. (Ctrl7.62203 
+/- 0.83 Hz, MPEP 7.95877+/- 1.10 Hz; Ctrl 19.16708 +/- 0.98 pAMPEP 18.83072 +/- 0.69 pA, 
n=7,p=0.61 and p=0.62 respectively, Paired sample T-test; Ctrl 6.19 +/-0.67606  MCPG 6.66+/- 
0.71Hz; Ctrl 19.46 +/-0.97 MCPG18.66 +/-1.18,n=8, p=0.10 and p=0.13, Paired sample T-test.) 
 
TRPV1 activation stimulates the release of microglia-derived microvesicles 
 The molecular mechanism underlying the increase of mEPSC frequency driven by 
microglial TRPV1 activation remain the unresolved point. Several factors, drive 
microglia-to-neuron communication, through EVs shed from the plasma 
membrane of microglia, called microvesicles (MVs) or ectosomes119,120,121.Has 
been reported that the production of MVs increases in reactive microglia175, and is 
strongly enhanced by ATP through activation of P2X7 receptors
119. Assessed this 
idea, we hypothesized that TRPV1 stimulation on microglia should promote MV 
shedding as in P2X7 activation. To verify this hypothesis, cultured murine microglia 
were incubated with capsaicin (300 nM) for 10 min and EVs, both shed MVs and 
smaller vesicles, were quantified and sized by nanoparticle tracking analysis (NTA). 
NTA showed a multimodal size distribution of quite large vesicles, presumably 
MVs (mean diameter control= 298.2±21.2 nm; capsaicin= 305.0±16.32 nm; n=3), 
with a major peak consisting of vesicles about 200 nm in size and few smaller 
peaks of larger MVs (Fig. 22a). EV concentration increased by 1.5 fold under 
TRPV1 or ATP stimulation (Fig. 22b, n=3). Selective quantification of MVs shed 
from microglia that have incorporated fluorescent phosphocholine (NBD-C6_HPC) 
in the plasma membrane, confirmed that both ATP and capsaicin enhance MV 
production to the same extent (Fig. 22c, n=3; p<0.05). These data strongly suggest 
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that TRPV1 activation on microglia may increase mEPSC rate on neurons by 
triggering release of MVs. 
To substantiate this, we employed a newly synthesized inhibitor of acid 
ceramidase(Bach A. et al. 2015), the ARN14988 , in order to prevent neuronal 
sphingosine production, which is essential for MV-induced stimulation of synaptic 
activity31. Furthermore, in slices pre-treated with ARN14988, capsaicin did not 
affect either frequency or amplitude of mEPSCs (Fig. 22d). To exclude possible 
inhibitory effects of ARN14988 on MV production or activity, microglia cultures 
were treated with the ceramidase inhibitor before exposure to capsaicin. 
quantification showed that ARN14988 did not inhibit capsaicin-induced MV 
release (Fig. 22 f). Furthermore, patch-clamp recordings revealed that MVs from 
ARN14988-treated cells maintained the capability to increase mEPSC frequency in 
cultured neurons (Fig. 22 g). To strongly demonstrate that MV released by 
microglia act on synaptic terminals of pyramidal cells and induce increasing in 
neurotransmitter release we tried to block MV mechanism of release upstream, 
blocking microglia MV release. Is reported that p38 MAPK is activated 
downstream by P2X7 ATP receptor and is essential for MV shedding 176 Given that 
p38 MAPK is activated even by TRPV1 receptors177 , we hypothesized that 
inhibition of p38 MAPK could block capsaicin-induced MV shedding in the same 
manner. Demonstrated that capsaicin-induced MV shedding from cultured 
microglia treated was significantly reduced in the presence of p38 MAPK inhibitor 
SB203580 (fig.22 h) we performed a similar experiment on acute slice.  Capsaicin 
failed to affect the frequency and amplitude of mEPSCs in slices incubated with 
SB203580 (Fig. 22 e) indicating that capsaicin might increase spontaneous 
glutamatergic synaptic activity by promoting shedding of microglial MVs, which in 
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turn stimulate sphingosine metabolism in neurons and enhances presynaptic 
release probability as reported in Antonucci et al. 2011. 
 
 
Figure 22: TRPV1  modulates synaptic transmission by microvesicles shedding (a) Representative 
size profile of EVs released constitutively (black line) or upon capsaicin challenge (red line) from 
5X10
5
 murine microglia in 500μl of serum free medium during a period of 10 minutes. (b) 
Histogram showing the fold increase of total EV concentration detected by Nanosight upon 
stimulation with ATP or capsaicin (Kruskal-Wallis test, p=0,035). (c) Histogram showing the fold 
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increase of MVs shed selectively from the plasma membrane and measured by a 
spectrophotometric assay under the same stimuli (Holm-Sidak’s, p<0,05). (d) Group data showing 
that addition of ARN14988 significantly counteracts capsaicin-mediated increase of mEPSC 
frequency in cortical slices (from 11.51±0.92 to 12.12±0.88 Hz, p=0.15; from 14.52±0.61 to 
14.10±0.46 pA, p=0.06, Paired Sample t-Test, n=10). (e) Summary graph of mEPSC frequency (left) 
and amplitude (right) in the presence of 2 M SB203580 before (black bar) and after capsaicin 
(blue bar) (from 9.30±1.00 to 9.93±0.90 Hz, p=0.08; from 10.67±0.47 to 10.75±0.49 pA, n=11, and 
p=0.89, Paired Sample t-Test and Wilcoxon Signed Rank Test, respectively).Data are values from 
single cells and/or mean±SEM. *p<0.05. (f)  Microglia cell cultures were challenged with vehicle, 
capsaicin or ARN+capsaicin and MVs shedding were measured. Histogram shows the fold increase 
of total EV concentration detected by Nanosight upon stimulation of microglia cultures with 
vehicle (ctrl, black bar), capsaicin (light gray bar) or ARN+capsaicin (dark grey bar; One way Anova 
*p<0.05,**p<0.01 Dunn's Method for multiple comparison test). (g) Changes of mEPSCs evoked by 
MVs previously treated with ARN+caps (ctrl n=10, caps n=8, p<0.01 Mann-Whitney Rank Sum 
Test). (h) Microglia cell cultures were challenged with vehicle, capsaicin or 400nM 
SB203580+capsaicin and MVs shedding were measured.  (violet bar; One way Anova 
****p<0.0001 followed by Tukey’s multiple comparison test) 
 
 
Lysophosphatidic acid(LPA) activates TRPV1 receptor 
Lysophosphatidic acid (LPA), a bioactive and proinflammatory signalling lipid is 
highly produced during inflammation189 and that activates microglial cells which in 
turn self-sustained LPA synthesis. Similarly to capsaicin, LPA was recently 
described as TRPV1 possible agonist despite this lipid have its own receptors. We 
demonstrate that as capsaicin, LPA significantly enhanced the frequency of 
mEPSCs (Fig.23a) and did not affect mEPSC amplitude (p<0.9). The enhancement 
of mEPSC rate by LPA was significantly dampened in slices incubated with IRTX 
(Fig. 23b-c). Accordingly LPA triggers excitatory neurotransmission even when its 
own when metabotropic receptors were blocked(Fig.23d) this effect was 
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completely abolished when both TRPV1 and LPA receptors were counteracted 
(Fig.23e), suggesting that LPA may behave as a potential endogenous activator of 
TRPV1 in the brain during pathological inflammation.  
 
 
Figure 23: LPA is the potential TRPV1 agonist during acute inflammation (a) Summary graph of 
mEPSC frequency and amplitude before (black bar; 9.10±0.96 Hz and 15.43±0.95 pA, n=10) and 
during 5 M LPA (orange bar; 11.32±1.1 Hz and 15.38±1.07 pA, n=10). LPA significantly boost 
mEPSC frequency (p<0.002; Wilcoxon Signed Ranks Test). (b) Same as in previous graphs but in the 
presence of IRTX (IRTX 10.41±0.76.14, IRTX+LPA 11.54±1 Hz, n=13; p<0.05 Paired Sample T Test; 
IRTX 12.92±0.93,IRTX+LPA 13.01±0.93 pA, n=13).. (c) Note that LPA is significantly less effective 
when TRPV1 is inhibited (p<0.05, Two-sample T test) (*p<0.05, **p<0.001). (d-e) In the presence 
of LPA1-4 metabotropic receptors antagonist BrP-LPA, LPA increases glutamatergic transmission by 
TRPV1 activation. (d) Left, summary graphs of mEPSC frequency and amplitude before (black bar; 
12.21±1.32 Hz and 16.31±1.9 pA, n=9), during BrP-LPA (5 M; grey bar; 11.32±1.1 Hz and 
15.95±1.4 pA, n=9) and with LPA (green bar; 12.94±1.3 Hz and 15.00±1.2 pA, n=9). (e), same as in f 
but with the addition of IRTX (ctrl 11.71±1.14 Hz, BrLPA 12.03±1.15 Hz,  BrLPA+LPA 11.67±1.16 Hz, 
n=8; ctrl 15.70±1.70 pA, BrLPA 15.16±1.80 pA, BrLPA+LPA 14.31±1.60 pA, n=8). (*p<0.05, Paired 
Sample t-Test).  
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TRPV1 controls cortical microglia activation and is involved in acute 
inflammatory response 
 Resident microglia in physiological conditions continuously check the brain 
microenvironment and maintain its correct homeostasis. Upon an insult these 
cells activate immune response shifting to an activated state characterized by 
dramatic  changes in the cellular shape, in functional behavior and through  the 
release of different proinflammatory and immunoregulatory factors. Capsaicin is 
reported to be capable of inducing microglial chemotaxis, and our collected data 
suggesting that could also regulate microglial activation in vitro. So we answered 
whether TRPV1 stimulation could directly induce functional changes (morphology, 
citokines release) on ex vivo microglial cells. Morphometric analyses (ImageJ 
plugin, Fig. 24) was performed on microglial cells from acute ACC slices. In control 
conditions (ACSF) iba1 positive cells presented a small cell body with thin and 
elongated processes (Fig. 25a,g).In capsaicin treated slices (10 minutes,capsaicin 1 
mM), iba1 positive cells  displayed a gain of hypertrophied branches and a larger 
cell bodies. (Fig.25 c,g). Capsaicin-induced morphological changes were absent in 
sections from TRPV1-/- mice (Fig. 25f,h), whereby microglia appeared already in an 
activated state in baseline conditions (Fig.25d-f,h). Subsequent flow cytometry 
experiments revealed that acute isolated cortical WT microglia treated with 
capsaicin produced  significantly higher levels of proinflammatory citokine TNF-
alpha accompained by a decrease in protective citokine IL-10 (Fig25i,l), on the 
other side  TRPV1-/- microglia expressed equal amounts of TNF-alpha after 
capsaicin exposure and compared to WT microglia produce a significantly greater 
amounts of IL-10 in basal  condition, capsaicin treatment did not alter this balance 
neither the TNF-alpha production(Fig.25i,l). The eventual role of interleukine 1-
beta(IL-1beta), another major pro-inflammatory chemokine released by 
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stimulated microglia, was excluded in both the groups. In fact in patch-clamp 
experiments  the presence of IL1-beta receptor antagonist primarily incubated on 
acute cortical slices was not sufficient to prevent capsaicin-mediated effect on 
mEPSCs (Fig.26).   
Confirmed the direct role of TRPV1 in controlling inflammatory microglia 
response, we next asked whether TRPV1 might be endogenously active under 
inflammatory conditions as in acute inflammatory environment induced 
experimentally   by stimulating slices with Lipopolysaccharide (LPS), the most 
abundant component within the cell wall of Gram-negative bacteria.In 
electrophysiology experiments, 500ng/ml LPS increased per se the mEPSC 
frequency without affecting their amplitude (35% of mEPSC frequency 
enhancement, (Fig.27a,b).Furthermore, the overall LPS-induced increase of 
glutamatergic neurotransmission was significantly reduced by IRTX (n=14, p<0.05; 
Fig. 27c right panel). Accordingly, the enhancement of mEPSCs and morphological 
changes induced by LPS were absent in TRPV1-/- mice (Fig. 28a-b) However, the 
application of capsaicin following LPS failed in inducing any further potentiation of 
mEPSCs(Fig.2 9a-b). Altogether, these results suggest that the TRPV1 activation 
might be responsible for microglia activation in inflammatory conditions.  
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Figure 24: Example of binary (digital) silhouettes of microglia cells from cortical slices acquired by 
transforming the tiff files of Iba1-immunoreactive cells to binary files by means of the ImageJ 
software. The cell area values and the TI were calculated for each silhouette and the obtained 
area:TI ratio value was used to classify each cell in a specific category (resting, ipertrophied, bushy 
and amoeboid). 
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Figure 25: The presence or absence of TRPV1 influences microglia phenotype. (a-f) Sections of 
cortical tissue from WT and TRPV1
-/-
 mice, fixed after exposure to aCSF (a,d), aCSF plus vehicle 
(DMSO; b,e) and aCSF plus 1M capsaicin (c,f) and immune-processed for iba-1 to stain microglia 
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cells (in red). INSETs are zoom images taken from an area delimited by the yellow square for each 
condition. (g), Bar graph of percentage of cortical microglia cell phenotype (resting, ameboid, 
bushy and hypertrophied), in control (grey bars), vehicle- (dark grey bars) and capsaicin- treated 
(red bars) cortical sections from WT mice. Capsaicin treatment causes a significant shift from 
resting and bushy to hypertrophied state. (h), Same as in “g” but in cortical sections from TRPV1
-/-
 
mice. In these tissues capsaicin fails to induce morphological changes of microglia cells. Note that 
microglia cells in -/- tissues are already hypertrophied in control conditions (d,e,f and h). *p<0.05, 
**p<0.01 Fisher exact test. Acutely isolated CD11b+ microglial cells from WT (i) and TRPV1
-/-
 mice 
(l) were cultured in the absence (-) or presence (+) of capsaicin (1μM) for 10 minutes, washed and 
then incubated with Brefeldin A for 6 hours to allow cytokine accumulation in vesicles. Intracellular 
production of TNF-α and IL-10 was analyzed by means of flow cytometry. Data represent 
percentage of cytokine production ± SEM of 3 independent pools of at least 3 mice. *p<0.05, 
**p<0.01 (Bonferroni’s multiple comparison test following parametric one-way Anova). 
 
 
Figure 26: IL1beta is not involved in microglia TRPV1-dependent modulation of excitatory 
neurotransmission. Summary graph of mEPScs frequency and amplitude in the presence of 
IL1beta receptor antagonist and after plus the application of capsaicin ( mEPSCs frequency from 
3.41 +/-0.48 to 5.04 +/-0.37 Hz ,n=11, p= 0.00048 paired sample T-test; amplitude from 15.15 +/-
1.21  to 15.34 +/-1.18 pA ,n=11;p= 0.20 paired sample T-test ). 
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27: TRPV1 tonically controls LPS-mediated effects. (a) Example recording of mEPSCs in control 
(ctrl) and during LPS exposure (500ng/ml). Below the cumulative probability plot of mEPSC 
interevent interval and amplitude (p<0.01 and p=0.24, respectively, KS test). (b) Population plot of 
mEPSC frequency before (black bar and filled circle) and during LPS (violet bar and filled circle), 
showing that LPS, similarly to capsaicin, increases selectively the mEPSC frequency (from 7.67±1.32 
to 10.09±1.73 Hz, n=14, p<0.001 Paired Sample Wilcoxon Signed Rank test) without a significant 
effect on the amplitude (from 20.05±1.30 to 19.76±1.32 pA, p=0.5 Paired Sample t-Test). (c) As in 
b, but in the presence of 300 nM IRTX (from 6.8±1.06 to 7.78±1.19 Hz, n=14, p<0.01 Paired Sample 
Wilcoxon Signed Rank test; from 17.47±1.17 to 17.11±1.23 pA, p=0.09 Paired Sample Wilcoxon 
Signed Rank test). Right, the percentage increase of mEPSC frequency by LPS in the presence of 
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the TRPV1 antagonist IRTX, is significantly reduced compared with the rate enhancement induced 
by LPS applied alone (p=0.01 Mann-Whitney test). 
 
 
 
Figure 28 TRPV1 controls microglia inflammatory response a) Population data of mEPSC 
frequency in control and during LPS obtained from PNs of TRPV1-/- mice (from 7.36±1.90 to 
7.69±1.81 Hz, n=9, p=0.52 Two Samples t-Test). (b) Stack column graph showing a greater 
percentage of activated cells (striped bar) related to resting microglia (filled bar) in WT slices (grey 
bars) treated for 10 minutes with LPS (500ng/ml). The same treatment carried out on slices from 
TRPV1-/- mice (blue bars) produced no changes in the number of activated cells. (*p<0.05, 
**p<0.01 Fisher's exact test). 
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Fig:29 LPS pretreatment occludes TRPV1 mediated effect (a) Trace records from a PN in control 
condition (ctrl), in LPS and LPS plus capsaicin. Following LPS perfusion, capsaicin is no longer able 
to further facilitate glutamatergic neurotransmission. (b) Right below, cumulative distribution 
probability of the interevent intervals from the same neuron (ctrl vs LPS p>0.0001, LPS vs caps 
p<0.0001, ctrl vs caps p=0.54).Left below a summary graph of mEPSC frequency before (black bar), 
during LPS (violet bar) and LPS+caps (red bar) (ctrl 6.69±1.15  LPS 8.78±1.68 Hz, LPS+caps 
8.45±1.97 Hz, n=7,ctrl vs LPSp<0.05, LPS vs LPS+caps p=0.68, ctrl vs LPS+caps p=0.15 Paired Sample 
t-Test;. Data are values from single cells and/or mean + SEM. *p<0.05, **p<0.001. 
 
TRPV1 neuronal distribution directly affects intrinsic membrane properties and 
synaptic strength of cortical principal neurons 
As reported TRPV1 receptor was expressed in time dependent manner on 
neuronal cells 2 weeks after the CCI of sciatic nerve. In order to confirm its 
functional role electrophysiology experiments were performed.  
In first we assessed that, in baseline conditions, neither Input resistance (shams 
137.37±9.9 MΩ n=24, CCI 147.12±10.6 MΩ n=23, p=0.5, Two Samples t-Test) nor 
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resting membrane potential (shams -70.96± 1.52 mV n=24, CCI -67.93±2.65 mV 
n=23,p=0.32, Two Samples t-Test) of PNs neurons from sham and CCI mice are 
unchanged suggesting that passive properties of membranes are not affected by 
TRPV1 expression on principal cells. In parallel, mEPSC frequency was enhanced in 
CCI mice compared to control animals (Fig.30a), whereas the amplitude of 
mEPSCs was strongly reduced (Fig.30b). The amplitude drop of spontaneous 
glutamatergic currents could be attributed to AMPA receptor trafficking as 
neuronal homeostatic mechanism subsequent to the persistent increase of 
synaptic activity 178. Instead, TRPV1 expression in the soma and dendrites of 
cortical pyramidal neurons (PNs) of CCI mice directly affect neuronal excitability. 
The number of action potentials evoked by current injections of increasing 
amplitude was significantly higher in CCI than shams(Fig.30d-left and right input-
output curves, respectively). The increase of firing can at least partly be ascribed 
to TRPV1 expression in CCI mice neurons, since IRTX caused a rightward shift in 
the input current to action potential rate curves (Fig.30e). 
Furthermore, as expected, application of capsaicin, besides frequency (as in 
control mice, see Fig. 30 f-g) significantly scaled up both amplitude and charge 
transfer of mEPSCs in CCI mice (12% and 16% increase, respectively; Fig. 30f). To 
dissect out microglial vs. neuronal TRPV1 contribution in such capsaicin-induced 
increase of synaptic strength, PNs from CCI mice were recorded also in the 
presence of minocycline. We found that, in these conditions  capsaicin 
significantly enhanced the mEPSC amplitude and the charge transfer in a subset of 
cells(fig.31 b), that could be TRPV1 positive, but not the frequency in the total of 
cells investigated suggesting that only neuronal TRPV1 account for capsaicin effect 
on miniature synaptic events amplitude, the increase in frequency is still 
dependent from microglial TRPV1(fig.31 a) 
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Beside its effects on the glutamatergic transmission, capsaicin  also induced a 
slight but consistent membrane depolarization associated with a significant 
reduction of the input resistance in PNs of CCI mice (Fig. 32a-b-c). This effect was 
independent from postsynaptic glutamatergic or GABAergic ionotropic receptors 
stimulation, as it was obtained in the presence of DNQX, APV and picrotoxin. 
Conversely, in neurons from shams we found no change in the same intrinsic 
membrane parameters (Fig.32b). Additionally, in voltage clamp experiments, 
capsaicin elicited rectifying inward currents associated with a significant 
enhancement of membrane conductance in CCI PNs, but not in shams (Fig. 32d-e), 
- effect that was significantly reverted by IRTX (Fig.32f-g).  
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Figure 30: Chronic ligature of sciatic nerve modifies basal synaptic excitability trough TRPV1 
expression   (a) On the left, cumulative probability curves of mEPSC interevent intervals for the 
total recorded neurons from sham (n=16, black line) and CCI mice (n=14, red line) (p<0.001 
Kolmogorov-Smirnov test). Right, summary histograms and line series plots of mEPSC from PNs of 
shams and CCI mice (6.47±0.58 and 8.63±0.92 Hz shams[n=16] and CCI mice [n=14], respectively 
p<0.05 Two sample T-test). (b) Left, cumulative probability distributions of mEPSC amplitudes of 
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total recorded PNs from shams (in black) and CCI (in red), p<0.001 KS test. Right, summary 
histograms and line series plots of mEPSC amplitudes from PNs of sham and CCI mice (16.76±0.65 
and 12.2±0.67 pA, respectively, p<0.01 Two sample T-test. (c) Comparison between average input-
out (input current/number of spikes) curvesfor the two conditions, shams (black dots) and CCI (red 
dots). The sciatic nerve ligation caused a leftward shift of the input current to action potential 
curves, with a significant increase of firing rate over a range of current injections. P<0.05 Mann-
Whitney test. (d) Average input current/number of spike curves for control (red) and after IRTX 
(green) from CCI PN recordings. The inhibition of TRPV1s significantly reverted the leftward shift of 
the input-output curve induced by the surgery of the sciatic nerve (*p<0.05, **p<0.005, Paired 
Sample Wilcoxon Signed Rank test). (e), Example recording of mEPSCs before (upper traces) and 
during capsaicin (below traces) from a CCI pyramidal neuron. Note that capsaicin increases both 
the frequency and amplitude of mEPSCs. (f), Cumulative probability plots comparing the interevent 
interval (IEI) (left panel), amplitude (middle panel) and area (right panel) of control mEPSCs with 
those recorded in capsaicin, (KS-test p<0.001). (g) Summary graph of mEPSC frequency (left), 
amplitude (middle) and peak area (right) before (black bar, solid circle) and during capsaicin (red 
bar, solid circles) (frequency from 6.73±1.05 to 7.66±1.02 Hz, p=0.05 Paired Sample t-Test; 
amplitude from 12.90±0.84 to 14.26±0.95 pA, p<0.01 Paired Sample Wilcoxon Signed Rank test; 
Area from 52.03±2.67 to 60.20±3.74 pA*ms, p<0.05 Paired Sample t- test; n=10). Data are values 
from single cells and mean + SEM. *p≤0.05.   
 
 
 
Figure 31: Microglial TRPV1 is not involved in the increase of neuronal synaptic strenght  (a) 
Summary graph of mEPSC frequency , amplitude of experiments performend in CCI mice in the 
presence of minocycline and in the presence of minociclyne plus capsaicine( mino 8.55±1.00 
mino+caps 9.27 ± 0.87  Hz, n=13 13  p=0.70 Paired Sample t-Test; mino 16.00 ±0.96  mino+caps 
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15.78 ± 0.86  pA, n=13 , p=0.64  Paired Sample t-Test);. Data are values from single cells and/or 
mean + SEM)  (b) Cumulative probability distributions of interevent intervals (left) amplitude 
(center) and area (left) of mEPSCs recorded from 4 cells of CCI mice in the presence of minocycline 
(p<0.01, KS test). 
 
 
 
Figure 32: Neuronal TRPV1 stimulation directly modulates layer 2/3 pyramidal neuron synaptic 
strength in CCI mice. (a) Current-clamp recording of a pyramidal neuron responding to capsaicin 
with depolarization and reduced RM in the presence of 6,7-dinitroquinoxaline-2,3-dione (10μM), 
D(−)-2-amino-5-phosphonovaleric acid (50μM) and picrotoxin (100μM). Negative deflections are 
membrane potential responses to negative current injections (60pA).(b) Plot of %RM (normalized 
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to pre- capsaicin values) versus ΔVM (membrane potential values in capsaicin subtracted from 
baseline ones) in all tested neurons from CCI and sham mice (n=18 and n=12, filled and white 
symbols, respectively). These data were analyzed by performing a linear fit to evaluate the 
strength of association between the two variables, through the coefficient of determination r
2
. In 
sham, RM values do not correlate with variations in ΔVM (r
2
=0.07) while in PNs from CCI mice, 
capsaicin-induced changes of VM correlate with a RM with a value of r
2
=0.36. (c) Summary time plot 
of subtracted membrane potential (VM) of CCI and sham PNs in response to capsaicin (p<0.001, 
Two Sample t-Test). (d) Left, example of voltage-clamp recording (at -70mV) of a CCI PN 
responding to capsaicin with an inward shift of the holding current, in the presence of tetrodotoxin 
(0.5μM), 6,7-dinitroquinoxaline-2,3-dione (10μM), D(−)-2-amino-5-phosphonovaleric acid (50μM) 
and picrotoxin (100μM). Vertical deflections (truncated in the figure) are membrane current 
responses to voltage steps to test passive properties (i.e. membrane conductance) and recording 
stability. Right, population graph of membrane conductance in control (black bar) and during 
capsaicin perfusion (red bar; n=12; *p<0.05 Paired Sample Wilcoxon Signed Rank test). (e), 
Summary plot of IM (membrane current values during capsaicin subtracted to baseline values) 
versus time for PNs from sham and CCI mice (n=12 and n=14, respectively; p<0.001, Mann-
Whitney test). (f) Voltage-clamp recording of layer 2/3 PN from a 4 week CCI mice in the presence 
of picrotoxin, APV, TTX, and DNQX. Application of capsaicin induced an inward current that was 
reverted by IRTX. (g) Summary plot of changes in IM after application of capsaicin and subsequent 
application of IRTX (n=4, *p<0.05 **p<0.01). 
 
 
 
 
 
 
 
 
 
 
 
 
89 
 
Discussion 
The present study shows that TRPV1 is abundantly expressed and functional in the 
microglia, rather than in neurons, of the anterior cingulate cortex of healthy mice. 
Notably, TRPV1 activation directly affects microglia function, which in turn 
modulates synaptic neurotransmission. This evidence is supported by: a) high 
levels of TRPV1 protein expression in cortical microglia cells as indicated by 
western blotting, flow cytometry and immunofluorescence assays in cortical 
tissues; b) the outward rectifying current induced by capsaicin in microglia cells 
from cortical slices; c) the shedding of microvesicles from microglial surface upon 
capsaicin application; and d) morphological and phenotypic changes of microglial 
cells upon TRPV1 activation. Importantly, TRPV1-mediated increase of cortical 
spontaneous glutamatergic neurotransmission is absent when microglia is 
switched off by minocycline and is occluded by the inflammatory agent LPS. 
Conversely, we found that in the cortex of mice suffering from neuropathic pain, 
TRPV1 is expressed also in neurons, affecting their intrinsic electrical properties 
and synaptic strength. This different TRPV1 expression pattern under chronic pain 
conditions places microglial TRPV1 at the center of a new important mechanism, 
providing a link between physiological and pathological states. 
TRPV1 is functional in microglia122,123,124 and growing evidence indicates a 
modulatory role of excitatory neurotransmission by microglia cells116,117. In 
addition, our study demonstrates that, under resting conditions, acute activation 
of TRPV1 expressed in microglia, rather than in neurons, accounts for its 
presynaptic modulation of neurotransmission widely observed in several rodent 
brain areas 76,77,78. 
The results from our study may also add new insights on the controversy with 
regards to the postsynaptic localization of TRPV1 and its role in modulating 
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presynaptic neurotransmitter release at several central synapses85,86. The use of a 
specific monoclonal antibody allowed us to reveal microglial TRPV1 expression, 
that was not detectable with the polyclonal antibodies commercially available 
used in previous investigations to indicate a pure neuronal TRPV1 localization53. 
Moreover, a microglial expression explains the apparent paradox of a postsynaptic 
TRPV1 localization inducing pre-synaptic effect on glutamate release. 
In contrast to the high levels of TRPV1 in microglia, we found a very low amount 
of this protein in cortical acutely isolated neurons, and both immunofluorescence 
and electrophysiological experiments in cortical slices showed that TRPV1s are not 
detectable and do not alter neuronal intrinsic properties. Evidence using TRPV1 
reporter transgenic mice, based on IRES polycistronic mRNA transcribed from the 
TRPV1 genomic locus, suggested that this channel is restricted to both low level 
expression and few brain areas60. It is well known, though, that the expression 
downstream of IRES sequences is variable, and orders of magnitude lower than 
that from the cap-dependent translation of the primary mRNA. Thus, the ensuing 
expression pattern of the reporter genes might not precisely mimic the real 
expression of TRPV1, but reflect a limitation of the seemingly precise and sensitive 
method used60. In addition, the identity of the TRPV1-positive cells stained in the 
brain by lacZ reporter was not investigated and their neuronal identity not 
formally demonstrated60. Hence, those results from TRPV1 reporter mice are 
entirely consistent with ours, that demonstrate in a direct way the expression of 
TRPV1 in cortical microglia, with a well-validated anti TRPV1 monoclonal antibody, 
that does not react with TRPV1 knock-out sections.  
Remarkably, the present data clarify the TRPV1 role in the brain with respect to 
that held by the same receptors in the peripheral somatosensory system. Indeed, 
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TRPV1s expressed in the main immune cells of the brain may similarly function as 
detectors of nociceptive and inflammatory stimuli/agents.  
Accordingly, we found that capsaicin shifted microglia to a hypertrophic and pro-
inflammatory state by increasing the production and release of cytokines i.e. 
showed increase production of IL6 and ROS formation following TRPV1 
activation in microglial cells 101,102,124. Notably, during inflammation or upon more 
generic environmental cellular insults, potential endovanilloids such as n-acyl 
amides, monoacylglycerols and bioactive lipids markedly increase 179,180. Among 
these candidates, LPA seems to be a suitable endogenous agonist since, similarly 
to capsaicin, it activates potassium outward currents in microglia cells and induces 
microglial microvesicles shedding 181. Our present data unveil a TRPV1-mediated 
enhancement of excitatory neurotransmission by LPA. Certainly, other candidates 
cannot be excluded  
Remarkably, the present study shows that TRPV1 is expressed and functional in 
the microglia, rather than in neurons, of the anterior cingulate cortex of healthy 
mice. Notably, TRPV1 activation directly affects microglia function, which in turn 
modulates synaptic neurotransmission. This evidence arises from: a) mRNA TRPV1 
expression in cortical microglia, validated by the lack of expression in cells from 
knock out tissue as negative control; b) high levels of TRPV1 protein expression in 
cortical microglia cells as indicated by western blotting, flow cytometry and 
immunofluorescence assays in cortical tissue; b) the outward rectifying current 
induced by capsaicin in microglia cells from cortical slices; c) the shedding of 
microvesicles from microglial surface upon capsaicin application; and d) 
morphological and phenotypic changes of microglial cells upon TRPV1 activation. 
Importantly, TRPV1-mediated increase of cortical spontaneous glutamatergic 
neurotransmission is absent when microglia is switched off by minocycline and is 
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occluded by the inflammatory agent LPS. Conversely, we found that in the cortex 
of mice suffering from neuropathic pain, TRPV1 is expressed also in neurons, 
affecting their intrinsic electrical properties and synaptic strength. This different 
TRPV1 expression pattern under chronic pain conditions places microglial TRPV1 
at the center of a new important mechanism, providing a link between 
physiological and pathological states. 
TRPV1 is functional in microglia and growing evidence indicates a modulatory role 
of excitatory neurotransmission by microglia cells. Accordingly, our study 
demonstrates that, in resting conditions, acute activation of TRPV1 expressed in 
microglia accounts for the well-known presynaptic modulation of glutamatergic 
neurotransmission by this channel observed in several rodent brain areas, and 
adds new insights on the apparent paradox of a postsynaptic TRPV1 localization 
inducing presynaptic effect on glutamate release15,61. In addition to the 
glutamatergic hypothesis, microglia affects neuronal excitability also by 
disinhibition mechanisms62, thus likely explaining the TRPV1 regulation of 
inhibitory neurotransmission at dentate gyrus synapses63. Differently, in 
“activated” conditions, our evidence on TRPV1 functional expression in neurons 
may argue for the postsynaptic TRPV1 modulation of some forms of long term 
depression21–24. 
Hence, the use of a specific monoclonal antibody allowed us to reveal microglial 
TRPV1 expression, that was not detectable with the commercially available 
polyclonal antibodies used in previous investigations which rather provided a pure 
neuronal and sparse astrocytic TRPV1 localization19,64. This conclusion is 
complemented by the evidence at the mRNA level, exploiting probes covering the 
exon sequence lacking in the TRPV1 mutant mice: TRPV1 mRNA is copiously 
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expressed in cortical microglial cells, as well as in neurons, while no significant 
amount is detected in TRPV1-/- tissue and cells. 
Our data do not exclude the existence of a functional TRPV1 postsynaptically 
expressed. Neurons may express a different splice variant of the protein from that 
expressed by microglia cells, that may not be detected by the anti-TRPV1 MAb 
employed in IF in fixed tissue (although the anti-TRPV1 MAb recognized the native 
neuronal receptor in the cytofluometry assay on living neurons). In addition, this 
putative different form of the channel could be activated upon specific stimuli, 
thus not showing up under our experimental conditions of the 
immunofluorescence and electrophysiological analysis. Indeed, only models of 
long term synaptic plasticity unveil a TRPV1-mediated postsynaptic effect. 
Evidence using TRPV1 reporter transgenic mice, based on IRES polycistronic mRNA 
transcribed from the TRPV1 genomic locus, previously suggested that this channel 
is restricted to both low level expression and few brain areas16. It is well known, 
though, that the protein expression downstream of IRES sequences is variable, 
and can be orders of magnitude lower than that from the cap-dependent 
translation of the primary mRNA65,66. Also, it is well known that the precise 
genomic context around a reporter gene can significantly affect the chromatin 
organization of that locus and thus the expression pattern of the reporter gene. 
Finally, the RNA metabolism and regulation of the IRES containing mRNA in the 
TRPV1 reporter mouse might be different from that of the endogenous TRPV1 
mRNA. Thus, the ensuing expression pattern of the reporter genes might not 
precisely mimic the real expression of TRPV1, but reflect a limitation of the 
seemingly precise and sensitive method used16. In addition, the identity of the 
TRPV1-positive cells stained in the brain by lacZ reporter was not investigated and 
their neuronal identity was not formally demonstrated16. Intriguingly, these cells 
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could also very well include non neuronal cells such as the glial cells 
immunopositive for the TRPV1 monoclonal antibody recognized/identified in the 
present study. 
Remarkably, the present data clarify the TRPV1 role in the brain with respect to 
that held by the same receptors in the peripheral somatosensory system. Indeed, 
TRPV1s expressed in the main immune cells of the brain may similarly function as 
detectors of nociceptive and inflammatory stimuli/agents.  
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Conclusions and final remarks 
 The TRPV1 localization in microglia, detected in this study by using a monoclonal 
antibody, resolves the anatomical vs functional discrepancies mentioned above, 
offering a mechanism of vanilloid-mediated presynaptic modulation of 
neurotransmitter release by microglia. On the other hand, our data do not exclude 
the existence of a functional TRPV1 postsynaptically expressed. Neurons may 
express a different splice variant of the protein from that expressed by microglia 
cells, that may not be detected by the anti-TRPV1 MAb employed in IF in fixed 
tissue (although the anti-TRPV1 MAb recognized the native neuronal receptor in 
the cytofluometry assay on living neurons). In addition, this putative different 
form of the channel could be activated upon specific stimuli, thus not showing up 
under our experimental conditions of the immunofluorescence and 
electrophysiological analysis. Indeed, only models of long term synaptic plasticity 
unveil a TRPV1-mediated postsynaptic effect. 
Our study reveals a novel function and expression of TRPV1s in control conditions: 
they directly and indirectly control microglial functions and neurotransmission, 
respectively, thus providing a link between neuroinflammation and synaptic 
transmission alterations. This is an emerging issue that sees microglia as the 
fourth element of the quadripartite synapse. 
Our study confirms also evidence on the "on demand" TRPV1 neuronal expression 
during pathological conditions although we are conscious that these data will fuel 
the already present controversy and debate regarding TRPV1s in the brain.  
Overall, we describe that, in an healthy brain, TRPV1 can function as a detector of 
inflammatory stimuli and plays a key role in the communication between 
immuno-competent cells and neurons. Upon injury, this channel receptor can 
behave as a brain biomarker of inflammation. 
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The experiments reported in this study reveal a strategic distribution of TRPV1, 
which is modulated by pain induction with significantly different outcomes. 
Finally, our data clarify and resolve its role in the mouse brain, which appears 
similar to that fulfilled in the peripheral nervous system. In particular, given the 
role of microglia cells as immune component of the central nervous system, 
TRPV1 may represent a sentinel of the brain environment by participating to the 
continuous scanning of harmful stimuli.  
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